Respiratory Medicine Research

The Department of Respiratory and Sleep Medicine at the Royal Prince Alfred Hospital is a leader in both translational and clinical research. Many of our researchers are recognised as national and international leaders in their field.

Our main goal is to advance our understanding and treatment of lung diseases and sleep-related disorders. We carry out diverse research including both investigator-led and industry-sponsored studies, and provide supervision and support for numerous Higher Degree by Research students.

Selected Grants

Amount awarded	Grant and project details
$11,000,000	Department of Foreign Affairs and Trade, 2024-2028 Regional Health Partnerships Scheme. Investigator: Fox G.
$1,988,115	MRFF, 2024-2028 A Pragmatic Randomized Controlled Trial to Digitally Support Self-Management for Inhaler Device Technique and Medication Adherence among People with Chronic Obstructive Pulmonary Disease (COPD) and Comorbidities - The PRISIMA-PECO Trial. Investigators: Ansari, Hurst, Reddel H, Zwar, Dennis, Halcomb, Rhee, Joshi, Hosseinzadeh, Batterham, Jeet.
$680,214	ACTG-NIH, 2024-2027 The PHOENIx Trial. Investigator: Fox G.
$140,000	Sydney Health Partners, 2024-2025 Sleep Health Clinical Academic Group. Investigators: Yee B, Sivam S (Co-Chairs)
$2,542,500	NHMRC Centre of Research Excellence, 2023-2028 Interstitial Lung Disease, towards individualised care Investigator: Corte TJ (CIA)
$1,999,997	MRFF, 2023-2028 A Randomised Clinical Trial of Self Management Application in Pulmonary Fibrosis (REBUILD-SM Trial) RPA Investigator: Corte TJ
$1,954,171	NHMRC, 2023-2027 Transforming outcomes for Interstitial Lung Disease Investigator: Corte TJ (CIA)
$422,345	Jannsen Research Support, 2023-2027 PHSANZ Registry Investigator: Lau E (CIA)
$9,967,326	MRFF 2020 Rapid Applied Research Translation Grant Opportunity, 2022-2027 Scaling up infectious disease point-of-care testing for Indigenous people Investigator: Fox G
$4,773,516	NHMRC, 2022-2027 The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis Investigator: Fox G (CIA)
$1,987,293	NHRMC Leadership Fellow, 2022-2027 Transforming Outcomes for Pulmonary Fibrosis. Investigator: Corte T (CIA).
$3,149,133	NHMRC Investigator Grant, 2022-2026 New directions in global tuberculosis control Investigator: Fox G (CIA)
$1,999,323	MRFF Chronic Respiratory Conditions, 2022-2026 Treatable Traits in Interstitial Lung Disease (TTRILD) Study: The New Frontier. Investigator: Corte T (CIB).
$100,000	NSW Health Pathology Biospecimen Collection Grant, 2022-2025 Sydney Pulmonary Hypertension Biobank. Investigator: Lau E.
$2,216,631	MRFF, 2021-2025 Silicosis – Harnessing new ideas to conquer the re-emergence of an ancient lung disease – The SHIELD Study Investigator: Corte T (CID)
$977,628	MRFF, 2021-2025 Activating primary care COPD patients with Multi-morbidity (APCOM) study. Investigators: Zwar, Yang, Reddel H, Hosseinzadeh, Ansari, Batterham, Salkeld.
$90,000	Lung Foundation Australia and The University of Sydney, 2021-2024 Novel diagnostic techniques in interstitial lung disease Investigator: Glenn L
$4,250,000	MRFF - Rapid Applied Research Translation, 2020-2025 Pathway to the Elimination of Antibiotic-Resistant Tuberculosis in the Pacific: The PEARL study Investigator: Fox G (CID)
$1,828,446	MRFF, 2020-2025 The TELO-SCOPE study: Attenuating Telomere Attrition with Danazol. Is there Scope to Dramatically Improve Health Outcomes for Adults and Children with Pulmonary Fibrosis? Investigator: Corte T (CIB)

Our Publications

2024

Professor Tamera Corte

Hoffman M, Burge AT, Wong N, McDonald CF, Chambers DC, Glaspole I, Mackintosh JA, Ekström M, Sköld M, Goh NSL, Corte TJ, Holland AE. Exertional Desaturation During the 6-Minute Walk Test vs Daily Life in People With Fibrotic Interstitial Lung Disease. Chest. 2024 Mar;165(3):632-635. doi: 10.1016/j.chest.2023.08.024. Epub 2023 Sep 1.

Zhao A, Gudmundsson E, Mogulkoc N, van Moorsel C, Corte TJ, Vasudev P, Romei C, Chapman R, Wallis TJM, Denneny E, Goos T, Savas R, Ahmed A, Brereton CJ, van Es HW, Jo H, De Liperi A, Duncan M, Pontoppidan K, De Sadeleer LJ, van Beek F, Barnett J, Cross G, Procter A, Veltkamp M, Hopkins P, Moodley Y, Taliani A, Taylor M, Verleden S, Tavanti L, Vermant M, Nair A, Stewart I, Janes SM, Young AL, Barber D, Alexander DC, Porter JC, Wells AU, Jones MG, Wuyts WA, Jacob J. Mortality surrogates in combined pulmonary fibrosis and emphysema. Eur Respir J. 2024 Apr 4;63(4):2300127. doi: 10.1183/13993003.00127-2023.

Tikellis G, Corte T, Glaspole IN, Goh NSL, Khor YH, Wrobel J, Symons K, Fuhrmeister L, Glenn L, Chirayath S, Troy LK, King B, Holland AE. Navigating the COVID-19 pandemic: Experiences and self-management approaches adopted by people with interstitial lung disease. Chron Respir Dis. 2024 Jan-Dec;21:14799731231226236. doi: 10.1177/14799731231226236.

Mackintosh JA, Keir G, Troy LK, Holland AE, Grainge C, Chambers DC, Sandford D, Jo HE, Glaspole I, Wilsher M, Goh NSL, Reynolds PN, Chapman S, Mutsaers SE, de Boer S, Webster S, Moodley Y, Corte TJ. Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology. 2024 Feb;29(2):105-135. doi: 10.1111/resp.14656. Epub 2024 Jan 11.

Lan D, Fermoyle CC, Troy LK, Knibbs LD, Corte TJ. The impact of air pollution on interstitial lung disease: a systematic review and meta-analysis. Front Med (Lausanne). 2024 Jan 17;10:1321038. doi: 10.3389/fmed.2023.1321038.

Richeldi L, Schiffman C, Behr J, Inoue Y, Corte TJ, Cottin V, Jenkins RG, Nathan SD, Raghu G, Walsh SLF, Jayia PK, Kamath N, Martinez FJ. Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial. Am J Respir Crit Care Med. 2024 May 1;209(9):1132-1140. doi: 10.1164/rccm.202401-0116OC.

Harrison M, Jo HE, Troy LK, Nguyen B, Webster SE, Geis M, Lai S, Mulyadi E, Cooper WA, Mahar A, Teoh A, Jee A, Corte TJ. Disease Behaviour Classification: A pragmatic model for predicting outcomes in Interstitial Lung Disease. Respir Med. 2024 Apr;224:107533. doi: 10.1016/j.rmed.2024.107533. Epub 2024 Feb 12.

Parker MJS, Jee AS, Hansen D, Proudman S, Youssef P, Kenna TJ, Stevens W, Nikpour M, Sahhar J, Corte TJ. Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis. Rheumatology (Oxford). 2024 Nov 1;63(11):2981-2988. doi: 10.1093/rheumatology/keae110.

Behr J, Salisbury ML, Walsh SLF, Podolanczuk AJ, Hariri LP, Hunninghake GM, Kolb M, Ryerson CJ, Cottin V, Beasley MB, Corte T, Glanville AR, Adegunsoye A, Hogaboam C, Wuyts WA, Noth I, Oldham JM, Richeldi L, Raghu G, Wells AU. The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions. Am J Respir Crit Care Med. 2024 Aug 15;210(4):392-400. doi: 10.1164/rccm.202401-0048PP.

Loganathan A, Zanframundo G, Yoshida A, Faghihi-Kashani S, Bauer Ventura I, Dourado E, Bozan F, Sambataro G, Yamano Y, Bae SS, Lim D, Ceribelli A, Isailovic N, Selmi C, Fertig N, Bravi E, Kaneko Y, Saraiva AP, Jovani V, Bachiller-Corral J, Cifrian J, Mera-Varela A, Moghadam-Kia S, Wolff V, Campagne J, Meyer A, Giannini M, Triantafyllias K, Knitza J, Gupta L, Molad Y, Iannone F, Cavazzana I, Piga M, De Luca G, Tansley S, Bozzalla-Cassione E, Bonella F, Corte TJ, Doyle TJ, Fiorentino D, Gonzalez-Gay MA, Hudson M, Kuwana M, Lundberg IE, Mammen AL, McHugh NJ, Miller FW, Montecucco C, Oddis CV, Rojas-Serrano J, Schmidt J, Scirè CA, Selva-O'Callaghan A, Werth VP, Alpini C, Bozzini S, Cavagna L, Aggarwal R; CLASS Project. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank. Clin Exp Rheumatol. 2024 Feb;42(2):277-287. doi: 10.55563/clinexprheumatol/s14zq8. Epub 2024 Mar 14.

Harrison M, Kavanagh G, Corte TJ, Troy LK. Drug-induced interstitial lung disease: a narrative review of a clinical conundrum. Expert Rev Respir Med. 2024 Jan-Feb;18(1-2):23-39. doi: 10.1080/17476348.2024.2329612. Epub 2024 Mar 19.

Jeganathan N, Corte TJ, Spagnolo P. Editorial: Epidemiology and risk factors for interstitial lung diseases. Front Med (Lausanne). 2024 Mar 6;11:1384825. doi: 10.3389/fmed.2024.1384825.

Mackintosh JA, Keir G, Corte TJ; authors. Reply to: Optimal clinical practice in IPF and PPF: Integrating scientific ethos and clinical reasoning. Respirology. 2024 May;29(5):432-433. doi: 10.1111/resp.14717. Epub 2024 Mar 27.

Adegunsoye A, Kropski JA, Behr J, Blackwell TS, Corte TJ, Cottin V, Glanville AR, Glassberg MK, Griese M, Hunninghake GM, Johannson KA, Keane MP, Kim JS, Kolb M, Maher TM, Oldham JM, Podolanczuk AJ, Rosas IO, Martinez FJ, Noth I, Schwartz DA. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine. Am J Respir Crit Care Med. 2024 Aug 15;210(4):401-423. doi: 10.1164/rccm.202401-0238SO.

Cox IA, de Graaff B, Zheng Q, Corte TJ, Haydn Walters E, Palmer AJ. Unravelling the health and economic burden of interstitial lung diseases in adults in Australia. Aust J Gen Pract. 2024 May;53(5):333-336. doi: 10.31128/AJGP-02-23-6713.

Reeves JM, Spencer LM, Tsai LL, Baillie AJ, Han Y, Leung RWM, Bishop JA, Troy LK, Corte TJ, Teoh AKY, Peters M, Barton C, Jones L, Alison JA. Effect of a 4-Week Telerehabilitation Program for People With Post-COVID Syndrome on Physical Function and Symptoms: Protocol for a Randomized Controlled Trial. Phys Ther. 2024 Sep 4;104(9):pzae080. doi: 10.1093/ptj/pzae080.

Fainberg HP, Moodley Y, Triguero I, Corte TJ, Sand JMB, Leeming DJ, Karsdal MA, Wells AU, Renzoni E, Mackintosh J, Tan DBA, Li R, Porte J, Braybrooke R, Saini G, Johnson SR, Wain LV, Molyneaux PL, Maher TM, Stewart ID, Jenkins RG. Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation. Lancet Respir Med. 2024 Sep;12(9):681-692. doi: 10.1016/S2213-2600(24)00147-4. Epub 2024 Jul 15.

Visser S, Lawler C, Fermoyle CC, Spencer LM, McAnulty AJ, Alison JA, Webster S, Troy L, Jo H, Hayen A, Corte TJ. The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung disease. Respir Med. 2024 Oct;232:107748. doi: 10.1016/j.rmed.2024.107748. Epub 2024 Jul 27.

Li A, Teoh A, Troy L, Glaspole I, Wilsher ML, de Boer S, Wrobel J, Moodley YP, Thien F, Gallagher H, Galbraith M, Chambers DC, Mackintosh J, Goh N, Khor YH, Edwards A, Royals K, Grainge C, Kwan B, Keir GJ, Ong C, Reynolds PN, Veitch E, Chai GT, Ng Z, Tan GP, Jackson D, Corte T, Jo H. Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease. Thorax. 2024 Oct 16;79(11):1024-1032. doi: 10.1136/thorax-2024-221813.

Barnes H, Corte TJ, Keir G, Khor YH, Limaye S, Wrobel JP, Veitch E, Harrington J, Dowman L, Beckert L, Milne D, De Losa R, Cooper WA, Bell PT, Balakrishnan P, Troy LK. Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand. Respirology. 2024 Dec;29(12):1023-1046. doi: 10.1111/resp.14847. Epub 2024 Oct 28.

Cartlidge MK, Brown KK, Chaudhuri N, Corte TJ, Dieudé P, John L, Kelly C, Khanna D, McRorie E, Nicol L, Stewart G, Walsh SLF, Wijsenbeek M, Hirani N; PASSWRD participants. A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease. BMC Pulm Med. 2024 Oct 31;24(1):547. doi: 10.1186/s12890-024-03287-0.

Sheehy R, McCormack S, Fermoyle C, Corte T. Sarcopenia in interstitial lung disease. Eur Respir Rev. 2024 Dec 4;33(174):240126. doi: 10.1183/16000617.0126-2024.

Desai SR, Sivarasan N, Johannson KA, George PM, Culver DA, Devaraj A, Lynch DA, Milne D, Renzoni E, Nunes H, Sverzellati N, Spagnolo P, Baughman RP, Yadav R, Piciucchi S, Walsh SLF, Kouranos V, Wells AU; Sarcoid Delphi Group. High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study. Lancet Respir Med. 2024 May;12(5):409-418. doi: 10.1016/S2213-2600(23)00267-9. Epub 2023 Dec 14.

Kawano-Dourado L, Kulkarni T, Ryerson CJ, Rivera-Ortega P, Baldi BG, Chaudhuri N, Funke-Chambour M, Hoffmann-Vold AM, Johannson KA, Khor YH, Montesi SB, Piccari L, Prosch H, Molina-Molina M, Sellares Torres J, Bauer-Ventura I, Rajan S, Jacob J, Richards D, Spencer LG, Wendelberger B, Jensen T, Quintana M, Kreuter M, Gordon AC, Martinez FJ, Kaminski N, Cornelius V, Lewis R, Adams W, Jenkins G; REMAP-ILD consortium. Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases. Thorax. 2024 Jul 16;79(8):788-795. doi: 10.1136/thorax-2023-221148. PMID: 38448221; PMCID: PMC11287572.

Raghu G, Richeldi L, Fernández Pérez ER, De Salvo MC, Silva RS, Song JW, Ogura T, Xu ZJ, Belloli EA, Zhang X, Seid LL, Poole L; ZEPHYRUS-1 Study Investigators. Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial. JAMA. 2024 Aug 6;332(5):380-389. doi: 10.1001/jama.2024.8693.

Lancaster L, Cottin V, Ramaswamy M, Wuyts WA, Jenkins RG, Scholand MB, Kreuter M, Valenzuela C, Ryerson CJ, Goldin J, Kim GHJ, Jurek M, Decaris M, Clark A, Turner S, Barnes CN, Achneck HE, Cosgrove GP, Lefebvre ÉA, Flaherty KR; PLN-74809-IPF-202 Trial Investigators. Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial. Am J Respir Crit Care Med. 2024 Aug 15;210(4):424-434. doi: 10.1164/rccm.202403-0636OC.

Dr Laura Glenn

Tikellis G, Corte T, Glaspole IN, Goh NSL, Khor YH, Wrobel J, Symons K, Fuhrmeister L, Glenn L, Chirayath S, Troy LK, King B, Holland AE. Navigating the COVID-19 pandemic: Experiences and self-management approaches adopted by people with interstitial lung disease. Chron Respir Dis. 2024 Jan-Dec;21:14799731231226236. doi: 10.1177/14799731231226236.

Dr Emma Gray

Eisen A, Nedergaard M, Gray E, Kiernan MC. The glymphatic system and Amyotrophic lateral sclerosis. Prog Neurobiol. 2024 Mar;234:102571. doi: 10.1016/j.pneurobio.2024.102571. Epub 2024 Jan 22.

Gray E, Menadue C, Piper A, Wong K, Kiernan M, Yee B. Hypercapnia is not excluded by normoxia in neuromuscular disease patients: implications for oximetry. ERJ Open Res. 2024 Jul 15;10(4):00927-2023. doi: 10.1183/23120541.00927-2023.

Gray E, Menadue C. The Role of High Flow Nasal Therapy in Chronic Respiratory Failure. Sleep Med Clin. 2024 Sep;19(3):461-472. doi: 10.1016/j.jsmc.2024.04.008. Epub 2024 Jun 12.

Professor Gregory Fox

Hasan T, Medcalf E, Nyang'wa BT, Egizi E, Berry C, Dodd M, Foraida S, Gegia M, Li M, Mirzayev F, Morgan H, Motta I, Nguyen L, Schumacher S, Schlub T, Fox G. The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis. Clin Infect Dis. 2024 Mar 20;78(3):730-741. doi: 10.1093/cid/ciad653.

Pham GN, Dang TTH, Nguyen TA, Zawahir S, Le HTT, Negin J, Schneider CH, Fox GJ. Health system barriers to the implementation of the national action plan to combat antimicrobial resistance in Vietnam: a scoping review. Antimicrob Resist Infect Control. 2024 Jan 25;13(1):12. doi: 10.1186/s13756-024-01364-x.

Alsdurf H, Benedetti A, Buu TN, Adjobimey M, Cook VJ, Fisher D, Fox G, Fregonese F, Hadisoemarto P, Johnston J, Long R, Obeng J, Oxlade O, Ruslami R, Schwartzman K, Strumpf E, Menzies D. Human resource implications of expanding latent tuberculosis patient care activities. Front Med (Lausanne). 2024 Jan 12;10:1265476. doi: 10.3389/fmed.2023.1265476.

Morgan H, Ndjeka N, Hasan T, Gegia M, Mirzayev F, Nguyen LN, Schumacher S, Schlub TE, Naidoo K, Fox GJ. Treatment of Multidrug-resistant or Rifampicin-resistant Tuberculosis With an All-oral 9-month Regimen Containing Linezolid or Ethionamide in South Africa: A Retrospective Cohort Study. Clin Infect Dis. 2024 Jun 14;78(6):1698-1706. doi: 10.1093/cid/ciae145.

Ruslami R, Fregonese F, Apriani L, Barss L, Bedingfield N, Chiang V, Cook VJ, Fisher D, Flores E, Fox GJ, Johnston J, Lim RK, Long R, Paulsen C, Nguyen TA, Nhung NV, Gibson D, Valiquette C, Benedetti A, Menzies D. High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial. Lancet Respir Med. 2024 Jun;12(6):433-443. doi: 10.1016/S2213-2600(24)00076-6. Epub 2024 Mar 26.

Menzies D, Obeng J, Hadisoemarto P, Ruslami R, Adjobimey M, Fisher D, Barss L, Bedingfield N, Long R, Paulsen C, Johnston J, Romanowski K, Cook VJ, Fox GJ, Nguyen TA, Valiquette C, Oxlade O, Fregonese F, Benedetti A. Sustainability and impact of an intervention to improve initiation of tuberculosis preventive treatment: results from a follow-up study of the ACT4 randomized trial. EClinicalMedicine. 2024 Mar 28;71:102546. doi: 10.1016/j.eclinm.2024.102546.

Teo AKJ, MacLean EL, Fox GJ. Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics. Eur Respir Rev. 2024 May 8;33(172):230208. doi: 10.1183/16000617.0208-2023.

Popovic I, Soares Magalhaes R, Yang S, Yang Y, Yang BY, Dong GH, Wei X, Van Buskirk J, Fox G, Ge E, Marks G, Knibbs L. Long-term exposure to ambient fine particulate matter (PM2.5) and attributable pulmonary tuberculosis notifications in Ningxia Hui Autonomous Region, China: a health impact assessment. BMJ Open. 2024 Jun 4;14(6):e082312. doi: 10.1136/bmjopen-2023-082312.

Seddon JA, McQuaid CF, Mafirakureva N, Hesseling AC, Fox GJ, Dodd PJ. Household contact management and preventive treatment for drug-resistant tuberculosis. Lancet Glob Health. 2024 Sep;12(9):e1387-e1388. doi: 10.1016/S2214-109X(24)00265-1.

O'Hara DV, Bassi A, Wilcox A, Jha V, Rathore V, D'Cruz S, Snelling TL, Jones M, Totterdell J, Bangi A, Jain MK, Pollock C, Burrell L, Fox G, Jones C, Kotwal S, Faridah Syed Omar S, Jardine M; CLARITY 2.0 trial investigators. Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial. BMJ Open. 2024 Oct 22;14(10):e081790. doi: 10.1136/bmjopen-2023-081790.

Greenall-Ota J, Yapa HM, Fox GJ, Negin J. Qualitative Evaluation of mHealth Implementation for Infectious Disease Care in Low- and Middle-Income Countries: Narrative Review. JMIR Mhealth Uhealth. 2024 Dec 13;12:e55189. doi: 10.2196/55189.

Fox GJ, Nhung NV, Cam Binh N, Hoa NB, Garden FL, Benedetti A, Ngoc Yen P, Cuong NK, MacLean EL, Yapa HM, Dowdy DW, Lan NH, Guevara-Rattray E, Duc Cuong P, Solomon O, Behr MA, Marais BJ, Graham SM, Menzies D, Thu Anh N, Marks GB. Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam. N Engl J Med. 2024 Dec 19;391(24):2304-2314. doi: 10.1056/NEJMoa2314325.

Dr Adelle Jee

Parker MJS, Jee AS, Hansen D, Proudman S, Youssef P, Kenna TJ, Stevens W, Nikpour M, Sahhar J, Corte TJ. Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis. Rheumatology (Oxford). 2024 Nov 1;63(11):2981-2988. doi: 10.1093/rheumatology/keae110.

Dr Helen Jo

Bell JM, Dwyer TJ, Cunich M, Dentice RL, Hutchings O, Jo HE, Lau EM, Lee WY, Nolan SA, Munoz P, Raffan F, Shah K, Shaw M, Taylor NA, Visser SK, Yozghatlian VA, Wong KKH, Sivam S. Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costs. Intern Med J. 2024 May;54(5):809-816. doi: 10.1111/imj.16258. Epub 2023 Oct 27.

Sultan MA, Kong Y, Story C, Caterson H, Dix C, Gad F, Dhaliwal JS, Dunkley S, Jo H, van Hal S, Passam F. Thrombo-inflammatory response in hospitalised patients with COVID-19: a single institution experience. Intern Med J. 2024 Jan;54(1):43-53. doi: 10.1111/imj.16285. Epub 2023 Dec 19.

Zhao A, Gudmundsson E, Mogulkoc N, van Moorsel C, Corte TJ, Vasudev P, Romei C, Chapman R, Wallis TJM, Denneny E, Goos T, Savas R, Ahmed A, Brereton CJ, van Es HW, Jo H, De Liperi A, Duncan M, Pontoppidan K, De Sadeleer LJ, van Beek F, Barnett J, Cross G, Procter A, Veltkamp M, Hopkins P, Moodley Y, Taliani A, Taylor M, Verleden S, Tavanti L, Vermant M, Nair A, Stewart I, Janes SM, Young AL, Barber D, Alexander DC, Porter JC, Wells AU, Jones MG, Wuyts WA, Jacob J. Mortality surrogates in combined pulmonary fibrosis and emphysema. Eur Respir J. 2024 Apr 4;63(4):2300127. doi: 10.1183/13993003.00127-2023.

Mackintosh JA, Keir G, Troy LK, Holland AE, Grainge C, Chambers DC, Sandford D, Jo HE, Glaspole I, Wilsher M, Goh NSL, Reynolds PN, Chapman S, Mutsaers SE, de Boer S, Webster S, Moodley Y, Corte TJ. Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology. 2024 Feb;29(2):105-135. doi: 10.1111/resp.14656. Epub 2024 Jan 11.

Harrison M, Jo HE, Troy LK, Nguyen B, Webster SE, Geis M, Lai S, Mulyadi E, Cooper WA, Mahar A, Teoh A, Jee A, Corte TJ. Disease Behaviour Classification: A pragmatic model for predicting outcomes in Interstitial Lung Disease. Respir Med. 2024 Apr;224:107533. doi: 10.1016/j.rmed.2024.107533. Epub 2024 Feb 12.

Visser S, Lawler C, Fermoyle CC, Spencer LM, McAnulty AJ, Alison JA, Webster S, Troy L, Jo H, Hayen A, Corte TJ. The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung disease. Respir Med. 2024 Oct;232:107748. doi: 10.1016/j.rmed.2024.107748. Epub 2024 Jul 27.

Li A, Teoh A, Troy L, Glaspole I, Wilsher ML, de Boer S, Wrobel J, Moodley YP, Thien F, Gallagher H, Galbraith M, Chambers DC, Mackintosh J, Goh N, Khor YH, Edwards A, Royals K, Grainge C, Kwan B, Keir GJ, Ong C, Reynolds PN, Veitch E, Chai GT, Ng Z, Tan GP, Jackson D, Corte T, Jo H. Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease. Thorax. 2024 Oct 16;79(11):1024-1032. doi: 10.1136/thorax-2024-221813.

Associate Professor Edmund Lau

Bell JM, Dwyer TJ, Cunich M, Dentice RL, Hutchings O, Jo HE, Lau EM, Lee WY, Nolan SA, Munoz P, Raffan F, Shah K, Shaw M, Taylor NA, Visser SK, Yozghatlian VA, Wong KKH, Sivam S. Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costs. Intern Med J. 2024 May;54(5):809-816. doi: 10.1111/imj.16258. Epub 2023 Oct 27.

Kearney K, Brown K, Celermajer DS, Collins N, Cordina R, Corrigan C, Dwyer N, Feenstra J, Keating D, Keogh A, Kotlyar E, Lavender M, McWilliams T, Williams T, Whitford H, Weintraub R, Wrobel J, Ellender C, Anderson J, Lau EM; PHSANZ Registry. Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy. Chest. 2024 Apr;165(4):967-977. doi: 10.1016/j.chest.2023.10.037. Epub 2023 Nov 10.

Lau E, Kotlyar E, Makanji Y, Yu DY, Tan JY, Casorso J, Kouhkamari MH, Lim S, Wu DB, Bloomfield P. Comparative adherence of macitentan versus ambrisentan and bosentan in Australian patients with pulmonary arterial hypertension: a retrospective real-world database study. J Med Econ. 2024 Jan-Dec;27(1):596-604. doi: 10.1080/13696998.2024.2328483. Epub 2024 Apr 10.

Chao HY, Yee BJ, Hsu CH, Chen HM, Lau EM. Sleep-related disorders in patients with precapillary pulmonary hypertension. Sleep Med Rev. 2024 Oct;77:101972. doi: 10.1016/j.smrv.2024.101972. Epub 2024 Jul 3.

Gerges C, Beurnier A, Jaïs X, Hervé P, Lau EMT, Girerd B, Günther S, Bouchachi A, Jevnikar M, Boucly A, Bogaard HJ, Simonneau G, Sitbon O, Savale L, Chemla D, Humbert M, Montani D. Role of Exercise Hemodynamics in the Prediction of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers. Chest. 2024 Nov;166(5):1173-1183. doi: 10.1016/j.chest.2024.06.3808. Epub 2024 Jul 24.

Nguyen BH, Menadue C, Yee BJ, McGuiness OA, Wong KK, Marshall NS, Lau EM, Piper AJ. Long-term mortality in patients with chronic obstructive pulmonary disease requiring acute non-invasive ventilation with and without obstructive sleep apnoea. BMJ Open Respir Res. 2024 Oct 23;11(1):e002496. doi: 10.1136/bmjresp-2024-002496.

Hungerford SL, Kearney K, Li C, Song N, Everett K, Gulati G, Olsen N, Lau E, Jabbour A, Bart N, Kotlyar E, Muller D, Hayward C, Kapur N, Adji A. Pulsatile Vascular Afterload Measurement Improves Prediction of Right-Sided Heart Dysfunction in Undifferentiated and Left-Sided Pulmonary Hypertension. J Am Heart Assoc. 2024 Dec 3;13(23):e034684. doi: 10.1161/JAHA.124.034684. Epub 2024 Nov 22.

Dr Stephen McNamara

Nanayakkara B, McNamara S. Pathophysiology of Chronic Hypercapnic Respiratory Failure. Sleep Med Clin. 2024 Sep;19(3):379-389. doi: 10.1016/j.jsmc.2024.04.001. Epub 2024 May 28.

Associate Professor Amanda Piper

Ucak S, Dissanayake HU, de Chazal P, Bin YS, Sutherland K, Setionago B, Tong B, Yee BJ, Kairaitis K, Wheatley JR, Piper AJ, Cistulli PA; Sydney Sleep Biobank Investigators. Heart rate variability analysis in obstructive sleep apnea patients with daytime sleepiness. Sleep. 2024 Jun 13;47(6):zsae075. doi: 10.1093/sleep/zsae075.

Zheng Y, Yee BJ, Wong K, Grunstein RR, Piper AJ. A comparison of two obesity-related hypoventilation disorders: Impact on sleep, quality of life and neurocognitive outcomes and the effects of positive airway pressure therapy. Sleep Adv. 2024 Mar 13;5(1):zpae016. doi: 10.1093/sleepadvances/zpae016.

Kemp E, Sutherland K, Bin YS, Chan ASL, Dissanayake H, Yee BJ, Kairaitis K, Wheatley JR, de Chazal P, Piper AJ, Cistulli PA; Sydney Sleep Biobank Investigators. Characterisation of Symptom and Polysomnographic Profiles Associated with Cardiovascular Risk in a Sleep Clinic Population with Obstructive Sleep Apnoea. Nat Sci Sleep. 2024 May 6;16:461-471. doi: 10.2147/NSS.S453259.

Ucak S, Dissanayake HU, Sutherland K, Yee BJ, Kairaitis K, Wheatley JR, Piper AJ, de Chazal P, Cistulli PA; Sydney Sleep Biobank Investigators. Cardiac autonomic function in REM-related obstructive sleep apnoea: insights from nocturnal heart rate variability profiles. Sleep Breath. 2024 Oct;28(5):1987-1996. doi: 10.1007/s11325-024-03091-4. Epub 2024 Jul 1.

Gray E, Menadue C, Piper A, Wong K, Kiernan M, Yee B. Hypercapnia is not excluded by normoxia in neuromuscular disease patients: implications for oximetry. ERJ Open Res. 2024 Jul 15;10(4):00927-2023. doi: 10.1183/23120541.00927-2023.

Piper AJ. Interfaces for Home Noninvasive Ventilation. Sleep Med Clin. 2024 Sep;19(3):431-441. doi: 10.1016/j.jsmc.2024.04.005. Epub 2024 May 28.

Piper AJ, McNamara S, Yee BJ. Updates on Chronic Respiratory Failure and Noninvasive Respiratory Support: Innovations and Insights. Sleep Med Clin. 2024 Sep;19(3):xiii-xv. doi: 10.1016/j.jsmc.2024.06.001. Epub 2024 Jun 21.

Nguyen BH, Menadue C, Yee BJ, McGuiness OA, Wong KK, Marshall NS, Lau EM, Piper AJ. Long-term mortality in patients with chronic obstructive pulmonary disease requiring acute non-invasive ventilation with and without obstructive sleep apnoea. BMJ Open Respir Res. 2024 Oct 23;11(1):e002496. doi: 10.1136/bmjresp-2024-002496.

Dr Helen Reddel

Beasley R, Hughes R, Agusti A, Calverley P, Chipps B, Del Olmo R, Papi A, Price D, Reddel H, Müllerová H, Rapsomaniki E. Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness. Am J Respir Crit Care Med. 2024 Feb 15;209(4):390-401. doi: 10.1164/rccm.202308-1436OC.

Ding B, Chen S, Rapsomaniki E, Quinton A, Cook W, Reddel HK, Papi A; NOVELTY Scientific Community; NOVELTY study investigators. Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers. J Allergy Clin Immunol Pract. 2024 Apr;12(4):970-982. doi: 10.1016/j.jaip.2023.12.021. Epub 2023 Dec 22.

Hatter L, Holliday M, Eathorne A, Bruce P, Pavord ID, Reddel HK, Hancox RJ, Papi A, Weatherall M, Beasley R. The carbon footprint of as-needed budesonide/formoterol in mild asthma: a post hoc analysis. Eur Respir J. 2024 Jul 11;64(1):2301705. doi: 10.1183/13993003.01705-2023.

Davis SR, Ampon RD, Poulos LM, Lee T, Marks GB, Toelle BG, Reddel HK. Prevalence and burden of difficult-to-treat and severe asthma in Australia: A national population survey. Respirology. 2024 Aug;29(8):685-693. doi: 10.1111/resp.14722. Epub 2024 May 6.

Sunjaya AP, Poulos LM, Di Tanna GL, Lung T, Marks GB, Reddel HK, Jenkins CR. The health and economic burden of breathlessness, Australia, 2019: a national survey. Med J Aust. 2024 Sep 16;221(6):324-332. doi: 10.5694/mja2.52425. Epub 2024 Aug 28.

Fernandez L, Reddel HK, Diaz D, Roa C Jr, Zotomayor R, Ramos J, Ocampo G, Cruz MV, Punongbayan R. Optimizing asthma care in low-to-middle income countries through multisectoral collaboration: recommendation report of the first Philippine Asthma Assembly. Expert Rev Respir Med. 2024 Dec;18(12):947-962. doi: 10.1080/17476348.2024.2389948. Epub 2024 Dec 10.

Dr Sheila Sivam

Bell JM, Dwyer TJ, Cunich M, Dentice RL, Hutchings O, Jo HE, Lau EM, Lee WY, Nolan SA, Munoz P, Raffan F, Shah K, Shaw M, Taylor NA, Visser SK, Yozghatlian VA, Wong KKH, Sivam S. Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costs. Intern Med J. 2024 May;54(5):809-816. doi: 10.1111/imj.16258. Epub 2023 Oct 27.

Anderson J, Yee BJ, Grunstein R, Matar E, Chadwick M, Machan E, Chapman J, Tai J, Saini B, Sivam S. Insights from a 10-year Australasian idiopathic hypersomnia patient data registry study. J Clin Sleep Med. 2024 Dec 1;20(12):1955-1964. doi: 10.5664/jcsm.11298.

Dr Aruvi Thiruvarudchelvan

Thiruvarudchelvan A, Silverstone E, Yates D. Asbestosis in an Australian brake mechanic. Med J Aust. 2024 Aug 5;221(3):145-146. doi: 10.5694/mja2.52371. Epub 2024 Jul 4.

Professor Paul Torzillo

Chang AB, Kovesi T, Redding GJ, Wong C, Alvarez GG, Nantanda R, Beltetón E, Bravo-López M, Toombs M, Torzillo PJ, Gray DM. Chronic respiratory disease in Indigenous peoples: a framework to address inequity and strengthen respiratory health and health care globally. Lancet Respir Med. 2024 Jul;12(7):556-574. doi: 10.1016/S2213-2600(24)00008-0. Epub 2024 Apr 24.

Chang AB, Yerkovich ST, Baines KJ, Burr L, Champion A, Chatfield MD, Eg KP, Goyal V, Marsh RL, McCallum GB, McElrea M, McPhail S, Morgan LC, Morris PS, Nathan AM, O'Farrell H, Sanchez MO, Parsons M, Schultz A, Torzillo PJ, West NP, Versteegh L, Marchant JM, Grimwood K. Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial. BMJ Open Respir Res. 2024 May 7;11(1):e002216. doi: 10.1136/bmjresp-2023-002216.

Leach AJ, Wilson N, Arrowsmith B, Beissbarth J, Mulholland K, Santosham M, Torzillo PJ, McIntyre P, Smith-Vaughan H, Skull SA, Oguoma VM, Chatfield MD, Lehmann D, Brennan-Jones CG, Binks MJ, Licciardi PV, Andrews RM, Snelling T, Krause V, Carapetis J, Chang AB, Morris PS. Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules. PLoS Med. 2024 Jun 3;21(6):e1004375. doi: 10.1371/journal.pmed.1004375.

Kok HC, McCallum GB, Yerkovich ST, Grimwood K, Fong SM, Nathan AM, Byrnes CA, Ware RS, Nachiappan N, Saari N, Morris PS, Yeo TW, Oguoma VM, Masters IB, de Bruyne JA, Eg KP, Lee B, Ooi MH, Upham JW, Torzillo PJ, Chang AB. Twenty-four Month Outcomes of Extended- Versus Standard-course Antibiotic Therapy in Children Hospitalized With Pneumonia in High-risk Settings: A Randomized Controlled Trial. Pediatr Infect Dis J. 2024 Sep 1;43(9):872-879. doi: 10.1097/INF.0000000000004407. Epub 2024 Jun 3.

Associate Professor Lauren Troy

Tikellis G, Corte T, Glaspole IN, Goh NSL, Khor YH, Wrobel J, Symons K, Fuhrmeister L, Glenn L, Chirayath S, Troy LK, King B, Holland AE. Navigating the COVID-19 pandemic: Experiences and self-management approaches adopted by people with interstitial lung disease. Chron Respir Dis. 2024 Jan-Dec;21:14799731231226236. doi: 10.1177/14799731231226236.

Mackintosh JA, Keir G, Troy LK, Holland AE, Grainge C, Chambers DC, Sandford D, Jo HE, Glaspole I, Wilsher M, Goh NSL, Reynolds PN, Chapman S, Mutsaers SE, de Boer S, Webster S, Moodley Y, Corte TJ. Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology. 2024 Feb;29(2):105-135. doi: 10.1111/resp.14656. Epub 2024 Jan 11.

Barton C, Troy L, Teoh A, Spencer L, Reeves J, Cram V, Wai M, Jones L. COVID-19 and collective trauma: Implementing a trauma-informed model of care for post-COVID patients. J Adv Nurs. 2024 Sep;80(9):3593-3599. doi: 10.1111/jan.16076. Epub 2024 Jan 31.

Lan D, Fermoyle CC, Troy LK, Knibbs LD, Corte TJ. The impact of air pollution on interstitial lung disease: a systematic review and meta-analysis. Front Med (Lausanne). 2024 Jan 17;10:1321038. doi: 10.3389/fmed.2023.1321038.

Harrison M, Jo HE, Troy LK, Nguyen B, Webster SE, Geis M, Lai S, Mulyadi E, Cooper WA, Mahar A, Teoh A, Jee A, Corte TJ. Disease Behaviour Classification: A pragmatic model for predicting outcomes in Interstitial Lung Disease. Respir Med. 2024 Apr;224:107533. doi: 10.1016/j.rmed.2024.107533. Epub 2024 Feb 12.

Harrison M, Kavanagh G, Corte TJ, Troy LK. Drug-induced interstitial lung disease: a narrative review of a clinical conundrum. Expert Rev Respir Med. 2024 Jan-Feb;18(1-2):23-39. doi: 10.1080/17476348.2024.2329612. Epub 2024 Mar 19.

Glaspole IN, Troy LK. Surgical lung biopsy for Idiopathic Pulmonary Fibrosis: Is the risk-benefit ratio changing. Respirology. 2024 Jul;29(7):533-534. doi: 10.1111/resp.14719. Epub 2024 Apr 2.

Reeves JM, Spencer LM, Tsai LL, Baillie AJ, Han Y, Leung RWM, Bishop JA, Troy LK, Corte TJ, Teoh AKY, Peters M, Barton C, Jones L, Alison JA. Effect of a 4-Week Telerehabilitation Program for People With Post-COVID Syndrome on Physical Function and Symptoms: Protocol for a Randomized Controlled Trial. Phys Ther. 2024 Sep 4;104(9):pzae080. doi: 10.1093/ptj/pzae080.

McDonald CF, Serginson J, AlShareef S, Buchan C, Davies H, Miller BR, Munsif M, Smallwood N, Troy L, Khor YH. Thoracic Society of Australia and New Zealand clinical practice guideline on adult home oxygen therapy. Respirology. 2024 Sep;29(9):765-784. doi: 10.1111/resp.14793. Epub 2024 Jul 15.

Visser S, Lawler C, Fermoyle CC, Spencer LM, McAnulty AJ, Alison JA, Webster S, Troy L, Jo H, Hayen A, Corte TJ. The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung disease. Respir Med. 2024 Oct;232:107748. doi: 10.1016/j.rmed.2024.107748. Epub 2024 Jul 27.

Li A, Teoh A, Troy L, Glaspole I, Wilsher ML, de Boer S, Wrobel J, Moodley YP, Thien F, Gallagher H, Galbraith M, Chambers DC, Mackintosh J, Goh N, Khor YH, Edwards A, Royals K, Grainge C, Kwan B, Keir GJ, Ong C, Reynolds PN, Veitch E, Chai GT, Ng Z, Tan GP, Jackson D, Corte T, Jo H. Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease. Thorax. 2024 Oct 16;79(11):1024-1032. doi: 10.1136/thorax-2024-221813.

Barnes H, Corte TJ, Keir G, Khor YH, Limaye S, Wrobel JP, Veitch E, Harrington J, Dowman L, Beckert L, Milne D, De Losa R, Cooper WA, Bell PT, Balakrishnan P, Troy LK. Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand. Respirology. 2024 Dec;29(12):1023-1046. doi: 10.1111/resp.14847. Epub 2024 Oct 28.

Dr Simone Visser

Bell JM, Dwyer TJ, Cunich M, Dentice RL, Hutchings O, Jo HE, Lau EM, Lee WY, Nolan SA, Munoz P, Raffan F, Shah K, Shaw M, Taylor NA, Visser SK, Yozghatlian VA, Wong KKH, Sivam S. Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costs. Intern Med J. 2024 May;54(5):809-816. doi: 10.1111/imj.16258. Epub 2023 Oct 27.

Visser S, Lawler C, Fermoyle CC, Spencer LM, McAnulty AJ, Alison JA, Webster S, Troy L, Jo H, Hayen A, Corte TJ. The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung disease. Respir Med. 2024 Oct;232:107748. doi: 10.1016/j.rmed.2024.107748. Epub 2024 Jul 27.

Associate Professor Keith Wong

Bell JM, Dwyer TJ, Cunich M, Dentice RL, Hutchings O, Jo HE, Lau EM, Lee WY, Nolan SA, Munoz P, Raffan F, Shah K, Shaw M, Taylor NA, Visser SK, Yozghatlian VA, Wong KKH, Sivam S. Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costs. Intern Med J. 2024 May;54(5):809-816. doi: 10.1111/imj.16258. Epub 2023 Oct 27.

Zheng Y, Yee BJ, Wong K, Grunstein RR, Piper AJ. A comparison of two obesity-related hypoventilation disorders: Impact on sleep, quality of life and neurocognitive outcomes and the effects of positive airway pressure therapy. Sleep Adv. 2024 Mar 13;5(1):zpae016. doi: 10.1093/sleepadvances/zpae016.

Gray E, Menadue C, Piper A, Wong K, Kiernan M, Yee B. Hypercapnia is not excluded by normoxia in neuromuscular disease patients: implications for oximetry. ERJ Open Res. 2024 Jul 15;10(4):00927-2023. doi: 10.1183/23120541.00927-2023.

Wang D, Martins RT, Rowsell L, Wong KK, Yee BJ, Grunstein RR, Eckert DJ. Comparison of awake respiratory control versus sleep obstructive sleep apnea endotypes. J Appl Physiol (1985). 2024 Dec 1;137(6):1524-1534. doi: 10.1152/japplphysiol.00138.2024. Epub 2024 Oct 10.

Nguyen BH, Menadue C, Yee BJ, McGuiness OA, Wong KK, Marshall NS, Lau EM, Piper AJ. Long-term mortality in patients with chronic obstructive pulmonary disease requiring acute non-invasive ventilation with and without obstructive sleep apnoea. BMJ Open Respir Res. 2024 Oct 23;11(1):e002496. doi: 10.1136/bmjresp-2024-002496.

Professor Brendon Yee

Matar E, Marshall NS, Yee BJ. Efficacy of intravenous iron for restless legs syndrome-moving beyond monotherapy and into the "real world". Sleep. 2024 Jul 11;47(7):zsae022. doi: 10.1093/sleep/zsae022. PMID: 38263487; PMCID: PMC11236947.

Lam AKF, Carrick J, Kao CH, Phillips CL, Zheng YZ, Yee BJ, Kim JW, Grunstein RR, Naismith SL, D'Rozario AL. Electroencephalographic slowing during REM sleep in older adults with subjective cognitive impairment and mild cognitive impairment. Sleep. 2024 Jun 13;47(6):zsae051. doi: 10.1093/sleep/zsae051.

Tai JE, Phillips CL, Yee BJ, Grunstein RR. Obstructive sleep apnoea in obesity: A review. Clin Obes. 2024 Jun;14(3):e12651. doi: 10.1111/cob.12651. Epub 2024 Feb 28.

Ucak S, Dissanayake HU, de Chazal P, Bin YS, Sutherland K, Setionago B, Tong B, Yee BJ, Kairaitis K, Wheatley JR, Piper AJ, Cistulli PA; Sydney Sleep Biobank Investigators. Heart rate variability analysis in obstructive sleep apnea patients with daytime sleepiness. Sleep. 2024 Jun 13;47(6):zsae075. doi: 10.1093/sleep/zsae075.

Zheng Y, Yee BJ, Wong K, Grunstein RR, Piper AJ. A comparison of two obesity-related hypoventilation disorders: Impact on sleep, quality of life and neurocognitive outcomes and the effects of positive airway pressure therapy. Sleep Adv. 2024 Mar 13;5(1):zpae016. doi: 10.1093/sleepadvances/zpae016.

Kemp E, Sutherland K, Bin YS, Chan ASL, Dissanayake H, Yee BJ, Kairaitis K, Wheatley JR, de Chazal P, Piper AJ, Cistulli PA; Sydney Sleep Biobank Investigators. Characterisation of Symptom and Polysomnographic Profiles Associated with Cardiovascular Risk in a Sleep Clinic Population with Obstructive Sleep Apnoea. Nat Sci Sleep. 2024 May 6;16:461-471. doi: 10.2147/NSS.S453259.

Ucak S, Dissanayake HU, Sutherland K, Yee BJ, Kairaitis K, Wheatley JR, Piper AJ, de Chazal P, Cistulli PA; Sydney Sleep Biobank Investigators. Cardiac autonomic function in REM-related obstructive sleep apnoea: insights from nocturnal heart rate variability profiles. Sleep Breath. 2024 Oct;28(5):1987-1996. doi: 10.1007/s11325-024-03091-4. Epub 2024 Jul 1.

Hoyos CM, Machan EA, Yee BJ, Postnova S, Marshall NS, Markovic T, Twigg SM, Grunstein RR, Phillips CL. Cardio-metabolic health effects of CPAP treatment for sleep apnoea during weight loss: A randomised controlled pilot trial. Obes Res Clin Pract. 2024 May-Jun;18(3):238-241. doi: 10.1016/j.orcp.2024.06.003. Epub 2024 Jul 2.

Gray E, Menadue C, Piper A, Wong K, Kiernan M, Yee B. Hypercapnia is not excluded by normoxia in neuromuscular disease patients: implications for oximetry. ERJ Open Res. 2024 Jul 15;10(4):00927-2023. doi: 10.1183/23120541.00927-2023.

Chao HY, Yee BJ, Hsu CH, Chen HM, Lau EM. Sleep-related disorders in patients with precapillary pulmonary hypertension. Sleep Med Rev. 2024 Oct;77:101972. doi: 10.1016/j.smrv.2024.101972. Epub 2024 Jul 3.

Nguyen BHM, Murphy PB, Yee BJ. Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Overlap Syndrome: An Update on the Epidemiology, Pathophysiology, and Management. Sleep Med Clin. 2024 Sep;19(3):405-417. doi: 10.1016/j.jsmc.2024.04.003. Epub 2024 May 28.

Piper AJ, McNamara S, Yee BJ. Updates on Chronic Respiratory Failure and Noninvasive Respiratory Support: Innovations and Insights. Sleep Med Clin. 2024 Sep;19(3):xiii-xv. doi: 10.1016/j.jsmc.2024.06.001. Epub 2024 Jun 21.

Anderson J, Yee BJ, Grunstein R, Matar E, Chadwick M, Machan E, Chapman J, Tai J, Saini B, Sivam S. Insights from a 10-year Australasian idiopathic hypersomnia patient data registry study. J Clin Sleep Med. 2024 Dec 1;20(12):1955-1964. doi: 10.5664/jcsm.11298.

Wang D, Martins RT, Rowsell L, Wong KK, Yee BJ, Grunstein RR, Eckert DJ. Comparison of awake respiratory control versus sleep obstructive sleep apnea endotypes. J Appl Physiol (1985). 2024 Dec 1;137(6):1524-1534. doi: 10.1152/japplphysiol.00138.2024. Epub 2024 Oct 10.

Tong BK, Ucak S, Dissanayake H, Patel S, Stewart GM, Sutherland K, Yee BJ, Allahwala U, Bhindi R, de Chazal P, Cistulli PA. Phenotypic Characterisation of Obstructive Sleep Apnoea in Acute Coronary Syndrome. Heart Lung Circ. 2024 Dec;33(12):1648-1658. doi: 10.1016/j.hlc.2024.07.014. Epub 2024 Oct 11.

Nguyen BH, Menadue C, Yee BJ, McGuiness OA, Wong KK, Marshall NS, Lau EM, Piper AJ. Long-term mortality in patients with chronic obstructive pulmonary disease requiring acute non-invasive ventilation with and without obstructive sleep apnoea. BMJ Open Respir Res. 2024 Oct 23;11(1):e002496. doi: 10.1136/bmjresp-2024-002496.

Zheng Y, Tai JE, Yee BJ. Management of central sleep apnoea: a review of non-hypercapnic causes. Breathe (Sheff). 2024 Nov 12;20(3):230235. doi: 10.1183/20734735.0235-2023.

Phillips CL, Chapman JL, Yee BJ. Weighing the evidence for excess weight and weight loss in the management of obstructive sleep apnea.'Fat' or fiction? Sleep Med Rev. 2024 Dec;78:102020. doi: 10.1016/j.smrv.2024.102020. Epub 2024 Nov 9.

Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using Cannabis and CBD to Sleep: An Updated Review. Curr Psychiatry Rep. 2024 Dec;26(12):712-727. doi: 10.1007/s11920-024-01564-7. Epub 2024 Nov 29. Erratum in: Curr Psychiatry Rep. 2024 Dec;26(12):728. doi: 10.1007/s11920-024-01580-7.

Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Correction: Using Cannabis and CBD to Sleep: An Updated Review. Curr Psychiatry Rep. 2024 Dec;26(12):728. doi: 10.1007/s11920-024-01580-7. Erratum for: Curr Psychiatry Rep. 2024 Dec;26(12):712-727. doi: 10.1007/s11920-024-01564-7.

2023

Professor Tamera Corte

Olsson KM, Corte TJ, Kamp JC, Montani D, Nathan SD, Neubert L, Price LC, Kiely DG. Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management. Lancet Respir Med. 2023 Sep;11(9):820-835. doi: 10.1016/S2213-2600(23)00259-X. Epub 2023 Aug 14. PMID: 37591300.

Zhao A, Gudmundsson E, Mogulkoc N, van Moorsel C, Corte TJ, Vasudev P, Romei C, Chapman R, Wallis TJM, Denneny E, Goos T, Savas R, Ahmed A, Brereton CJ, van Es HW, Jo H, De Liperi A, Duncan M, Pontoppidan K, De Sadeleer LJ, van Beek F, Barnett J, Cross G, Procter A, Veltkamp M, Hopkins P, Moodley Y, Taliani A, Taylor M, Verleden S, Tavanti L, Vermant M, Nair A, Stewart I, Janes SM, Young AL, Barber D, Alexander DC, Porter JC, Wells AU, Jones MG, Wuyts WA, Jacob J. Mortality surrogates in combined pulmonary fibrosis and emphysema. Eur Respir J. 2024 Apr 4;63(4):2300127. doi: 10.1183/13993003.00127-2023. PMID: 37973176; PMCID: PMC7616106.

Spagnolo P, Ryerson CJ, Guler S, Feary J, Churg A, Fontenot AP, Piciucchi S, Udwadia Z, Corte TJ, Wuyts WA, Johannson KA, Cottin V. Occupational interstitial lung diseases. J Intern Med. 2023 Dec;294(6):798-815. doi: 10.1111/joim.13707. Epub 2023 Aug 7. PMID: 37535448.

Jee AS, Stewart I, Youssef P, Adelstein S, Lai D, Hua S, Stevens W, Proudman S, Ngian GS, Glaspole IN, Moodley YP, Bleasel JF, Macansh S, Nikpour M, Sahhar J, Corte TJ; Australian Scleroderma Cohort Study, Australian Scleroderma Interest Group, Australian Idiopathic Pulmonary Fibrosis Registry, and associated investigators. A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis-Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study. Arthritis Rheumatol. 2023 Aug;75(8):1424-1433. doi: 10.1002/art.42491. Epub 2023 May 15.

Cox IA, Campbell J, de Graaff B, Otahal P, Corte TJ, Moodley Y, Hopkins P, Macansh S, Walters EH, Palmer AJ. Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D. Qual Life Res. 2023 Feb;32(2):473-493. doi: 10.1007/s11136-022-03205-z. Epub 2022 Aug 4.

Barnes H, Chambers D, Grainge C, Corte TJ, Bastiampillai S, Frenkel S, Westall G, Collard H, Glaspole I. Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire. Respirology. 2023 Apr;28(4):366-372. doi: 10.1111/resp.14404. Epub 2022 Nov 6.

Peljto AL, Blumhagen RZ, Walts AD, Cardwell J, Powers J, Corte TJ, Dickinson JL, Glaspole I, Moodley YP, Vasakova MK, Bendstrup E, Davidsen JR, Borie R, Crestani B, Dieude P, Bonella F, Costabel U, Gudmundsson G, Donnelly SC, Egan J, Henry MT, Keane MP, Kennedy MP, McCarthy C, McElroy AN, Olaniyi JA, O'Reilly KMA, Richeldi L, Leone PM, Poletti V, Puppo F, Tomassetti S, Luzzi V, Kokturk N, Mogulkoc N, Fiddler CA, Hirani N, Jenkins RG, Maher TM, Molyneaux PL, Parfrey H, Braybrooke R, Blackwell TS, Jackson PD, Nathan SD, Porteous MK, Brown KK, Christie JD, Collard HR, Eickelberg O, Foster EE, Gibson KF, Glassberg M, Kass DJ, Kropski JA, Lederer D, Linderholm AL, Loyd J, Mathai SK, Montesi SB, Noth I, Oldham JM, Palmisciano AJ, Reichner CA, Rojas M, Roman J, Schluger N, Shea BS, Swigris JJ, Wolters PJ, Zhang Y, Prele CMA, Enghelmayer JI, Otaola M, Ryerson CJ, Salinas M, Sterclova M, Gebremariam TH, Myllärniemi M, Carbone RG, Furusawa H, Hirose M, Inoue Y, Miyazaki Y, Ohta K, Ohta S, Okamoto T, Kim DS, Pardo A, Selman M, Aranda AU, Park MS, Park JS, Song JW, Molina-Molina M, Planas-Cerezales L, Westergren-Thorsson G, Smith AV, Manichaikul AW, Kim JS, Rich SS, Oelsner EC, Barr RG, Rotter JI, Dupuis J, O'Connor G, Vasan RS, Cho MH, Silverman EK, Schwarz MI, Steele MP, Lee JS, Yang IV, Fingerlin TE, Schwartz DA. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants. Am J Respir Crit Care Med. 2023 May 1;207(9):1194-1202. doi: 10.1164/rccm.202207-1331OC. Erratum in: Am J Respir Crit Care Med. 2024 Feb 15;209(4):462. doi: 10.1164/rccm.v209erratum2.

Zheng Q, Cox IA, Leigh L, de Graaff B, Johnston FH, Corte TJ, Knibbs LD, Otahal P, Navaratnam V, Campbell JA, Glaspole I, Moodley Y, Hopkins P, Mackintosh JA, Ahmad H, Walters EH, Palmer AJ. Long-term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from Australia. Respirology. 2023 Oct;28(10):916-924. doi: 10.1111/resp.14552. Epub 2023 Jul 11.

Barnes H, Humphries SM, George PM, Assayag D, Glaspole I, Mackintosh JA, Corte TJ, Glassberg M, Johannson KA, Calandriello L, Felder F, Wells A, Walsh S. Machine learning in radiology: the new frontier in interstitial lung diseases. Lancet Digit Health. 2023 Jan;5(1):e41-e50. doi: 10.1016/S2589-7500(22)00230-8. Epub 2022 Dec 12.

Wong AW, Sun H, Cox IA, Fisher JH, Khalil N, Johannson KA, Marcoux V, Assayag D, Manganas H, Kolb M, Palmer AJ, de Graaff B, Walters EH, Hopkins P, Zappala C, Goh NS, Moodley Y, Navaratnam V, Corte TJ, Ryerson CJ, Zhang W. Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease. PLoS One. 2023 Mar 31;18(3):e0283110. doi: 10.1371/journal.pone.0283110.

Lucas SEM, Raspin K, Mackintosh J, Glaspole I, Reynolds PN, Chia C, Grainge C, Kendall P, Troy L, Schwartz DA, Wood-Baker R, Walsh SLF, Moodley Y, Robertson J, Macansh S, Walters EH, Chambers D, Corte TJ, Dickinson JL. Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients. Pulmonology. 2023 May-Jun;29(3):257-260. doi: 10.1016/j.pulmoe.2022.09.002. Epub 2022 Oct 7.

Zheng Q, Cox IA, de Graaff B, Campbell JA, Corte TJ, Glaspole I, Navaratnam V, Hopkins P, Zappala C, Ahmad H, Zhao T, Macansh S, Walters EH, Palmer AJ. The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument. Qual Life Res. 2023 Jun;32(6):1609-1619. doi: 10.1007/s11136-022-03331-8. Epub 2022 Dec 26.

Tikellis G, Corte T, Glaspole IN, Goh N, Khor YH, Wrobel J, Symons K, Fuhrmeister L, Glenn L, Chirayath S, Troy L, Holland AE. Understanding the telehealth experience of care by people with ILD during the COVID-19 pandemic: what have we learnt? BMC Pulm Med. 2023 Apr 6;23(1):113. doi: 10.1186/s12890-023-02396-6.

Assayag D, Adegunsoye A, Sheehy R, Morisset J, Khalil N, Johannson KA, Marcoux V, Kolb M, Fisher JH, Manganas H, Wrobel J, Wilsher M, De Boer S, Mackintosh J, Chambers DC, Glaspole I, Keir GJ, Lee CT, Jablonski R, Vij R, Strek ME, Corte TJ, Ryerson CJ. Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia. Chest. 2023 May;163(5):1156-1165. doi: 10.1016/j.chest.2022.12.039. Epub 2023 Jan 5.

Cox IA, de Graaff B, Ahmed H, Campbell J, Otahal P, Corte TJ, Moodley Y, Goh N, Hopkins P, Macansh S, Walters EH, Palmer AJ. The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study. Eur J Health Econ. 2023 Sep;24(7):1121-1139. doi: 10.1007/s10198-022-01538-7. Epub 2022 Oct 27.

Glenn LM, Troy LK, Corte TJ. Novel diagnostic techniques in interstitial lung disease. Front Med (Lausanne). 2023 Apr 28;10:1174443. doi: 10.3389/fmed.2023.1174443.

Dr Laura Glenn

Tikellis G, Corte T, Glaspole IN, Goh N, Khor YH, Wrobel J, Symons K, Fuhrmeister L, Glenn L, Chirayath S, Troy L, Holland AE. Understanding the telehealth experience of care by people with ILD during the COVID-19 pandemic: what have we learnt? BMC Pulm Med. 2023 Apr 6;23(1):113. doi: 10.1186/s12890-023-02396-6.

Glenn LM, Troy LK, Corte TJ. Novel diagnostic techniques in interstitial lung disease. Front Med (Lausanne). 2023 Apr 28;10:1174443. doi: 10.3389/fmed.2023.1174443.

Professor Ron Grunstein

Judge DJ, Miller CB, Bartlett DJ, Jomaa I, Wong KKW, Saini B, Semsarian CR, Espie CA, Kyle SD, Grunstein RR, Yee BJ, Marshall NS. Armodafinil to reduce the sleepiness related side-effects of sleep restriction therapy being used to treat insomnia disorder: An open label clinical trial pilot study compared with historical controls. J Sleep Res. 2023 Feb;32(1):e13699. doi: 10.1111/jsr.13699. Epub 2022 Aug 24.

Stranks L, Ellender CM, Wong K, Naqvi H, Grunstein R, Yee BJ, Sivam S. Retrospective cohort study of hypersomnias of central origin from two Australian tertiary sleep disorders services. Intern Med J. 2023 Oct;53(10):1783-1789. doi: 10.1111/imj.15920. Epub 2022 Sep 17.

Teh JZ, Grummitt L, Haroutonian C, Cross NE, Skinner B, Bartlett DJ, Yee B, Grunstein RR, Naismith SL, D'Rozario AL. Overnight declarative memory consolidation and non-rapid eye movement sleep electroencephalographic oscillations in older adults with obstructive sleep apnea. Sleep. 2023 Jun 13;46(6):zsad087. doi: 10.1093/sleep/zsad087.

Lavender I, McCartney D, Marshall N, Suraev A, Irwin C, D'Rozario AL, Gordon CJ, Saini B, Grunstein RR, Yee B, McGregor I, Hoyos CM. Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial. BMJ Open. 2023 Aug 23;13(8):e071148. doi: 10.1136/bmjopen-2022-071148.

Tuft C, Matar E, Menczel Schrire Z, Grunstein RR, Yee BJ, Hoyos CM. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults. Clin Interv Aging. 2023 Jan 12;18:49-59. doi: 10.2147/CIA.S361519.

Marshall NS, Cho G, Toelle BG, Tonin R, Bartlett DJ, D'Rozario AL, Evans CA, Cowie CT, Janev O, Whitfeld CR, Glozier N, Walker BE, Killick R, Welgampola MS, Phillips CL, Marks GB, Grunstein RR. The Health Effects of 72 Hours of Simulated Wind Turbine Infrasound: A Double-Blind Randomized Crossover Study in Noise-Sensitive, Healthy Adults. Environ Health Perspect. 2023 Mar;131(3):37012. doi: 10.1289/EHP10757. Epub 2023 Mar 22.

Altree TJ, Aishah A, Loffler KA, Grunstein RR, Eckert DJ. The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial. J Clin Sleep Med. 2023 Jan 1;19(1):85-96. doi: 10.5664/jcsm.10256.

McCartney D, Kevin RC, Suraev AS, Sahinovic A, Doohan PT, Bedoya-Pérez MA, Grunstein RR, Hoyos CM, McGregor IS. How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trials. Drug Test Anal. 2023 Mar;15(3):334-344. doi: 10.1002/dta.3419. Epub 2022 Dec 19.

Aishah A, Loffler KA, Toson B, Mukherjee S, Adams RJ, Altree TJ, Ainge-Allen HW, Yee BJ, Grunstein RR, Carberry JC, Eckert DJ. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial. Ann Am Thorac Soc. 2023 Apr;20(4):584-595. doi: 10.1513/AnnalsATS.202206-492OC.

Comas M, Solis Flores A, Lovato N, Miller CB, Bartlett DJ, Grunstein RR, Chapman J, Gordon CJ. The Relationship between Anxiety, Subjective and Objective Sleep, Chronotype and Circadian Rhythms with Depressive Symptoms in Insomnia Disorder. Brain Sci. 2023 Apr 4;13(4):613. doi: 10.3390/brainsci13040613.

Kong SDX, Gordon CJ, Hoyos CM, Wassing R, D'Rozario A, Mowszowski L, Ireland C, Palmer JR, Grunstein RR, Shine JM, McKinnon AC, Naismith SL. Heart rate variability during slow wave sleep is linked to functional connectivity in the central autonomic network. Brain Commun. 2023 May 24;5(3):fcad129. doi: 10.1093/braincomms/fcad129.

Basheti MM, Bawa Z, Grunstein R, Grivell N, Saini B, Gordon CJ. Improving sleep health management in primary care: A potential role for community nurses? J Adv Nurs. 2023 Jun;79(6):2236-2249. doi: 10.1111/jan.15577. Epub 2023 Feb 9.

Cheung JM, Menczel Schrire Z, Aji M, Rahimi M, Salomon H, Doggett I, Glozier N, Bartlett DJ, Wong K, Grunstein RR, Gordon CJ. Embedding digital sleep health into primary care practice: A triangulation of perspectives from general practitioners, nurses, and pharmacists. Digit Health. 2023 Jun 23;9:20552076231180970. doi: 10.1177/20552076231180970.

Marshall NS, Grunstein RR. Orexin Agonists - Two Steps Forward, One Step Back. N Engl J Med. 2023 Jul 27;389(4):373-375. doi: 10.1056/NEJMe2305779.

Cayanan EA, Grunstein RR. Ketogenic diets for obesity-hypoventilation syndrome? Interesting physiology but a long way to go. Respirology. 2023 Aug;28(8):701-702. doi: 10.1111/resp.14540. Epub 2023 Jul 2.

Lee SKM, Smith L, Tan ECK, Cairns R, Grunstein R, Cheung JMY. Melatonin use in children and adolescents: A scoping review of caregiver perspectives. Sleep Med Rev. 2023 Aug;70:101808. doi: 10.1016/j.smrv.2023.101808. Epub 2023 Jun 16.

Grunstein RR, Wadden TA, Chapman JL, Malhotra A, Phillips CL. Giving weight to incretin-based pharmacotherapy for obesity-related sleep apnea: a revolution or a pipe dream? Sleep. 2023 Oct 11;46(10):zsad224. doi: 10.1093/sleep/zsad224.

Cheung JMY, Scott H, Muench A, Grunstein RR, Krystal AD, Riemann D, Perlis M. Comparative short-term safety and efficacy of hypnotics: A quantitative risk-benefit analysis. J Sleep Res. 2023 Nov 28:e14088. doi: 10.1111/jsr.14088. Epub ahead of print.

D'Rozario AL, Kao CH, Phillips CL, Mullins AE, Memarian N, Yee BJ, Duffy SL, Cho G, Wong KKH, Kremerskothen K, Chapman J, Haroutonian C, Bartlett DJ, Naismith SL, Grunstein RR. Region-specific changes in brain activity and memory after continuous positive airway pressure therapy in obstructive sleep apnea: a pilot high-density electroencephalography study. Sleep. 2023 Dec 11;46(12):zsad255. doi: 10.1093/sleep/zsad255.

Professor Gregory Fox

Gould GS, Hurst JR, Trofor A, Alison JA, Fox G, Kulkarni MM, Wheelock CE, Clarke M, Kumar R. Recognising the importance of chronic lung disease: a consensus statement from the Global Alliance for Chronic Diseases (Lung Diseases group). Respir Res. 2023 Jan 13;24(1):15. doi: 10.1186/s12931-022-02297-y.

Cheng Q, Dang T, Nguyen TA, Velen K, Nguyen VN, Nguyen BH, Vu DH, Long CH, Do TT, Vu TM, Marks GB, Yapa M, Fox GJ, Wiseman V. mHealth application for improving treatment outcomes for patients with multidrug-resistant tuberculosis in Vietnam: an economic evaluation protocol for the V-SMART trial. BMJ Open. 2023 Dec 11;13(12):e076778. doi: 10.1136/bmjopen-2023-076778.

Chang V, Nguyen TA, Nguyen B, Nguyen N, Fox G. Characteristics of Household Contacts of Rifampin and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease in Vietnam. Eur Resp J. 2023.

Chang V, Fox G. The use of weekly rifapentine and isoniazid (3HP) for latent TB infection in Australia. Eur Resp J. 2023.

Chang V, Nguyen V, Nguyen C, Nguyen T, Marks G, Fox G. Characteristics of household contacts of drug-resistant tuberculosis in Vietnam. Respirology. 2023.

Tran L, Dang T, Nguyen M, Kaufman J, Overmars I, Shrestha S, Abdi I, Nguyen T, Marahajan M, Chu T, Danchin M, Fox G, Nguyen TA. Behavioural and social drivers of COVID-19 vaccination in Vietnam: a scoping review. BMJ Open. 2023 Dec 21;13(12):e081134. doi: 10.1136/bmjopen-2023-081134.

Popovic I, Soares Magalhães RJ, Yang Y, Yang S, Yang B, Dong G, Wei X, Fox GJ, Hammer MS, Martin RV, van Donkelaar A, Ge E, Marks GB, Knibbs LD. Effects of long-term ambient air pollution exposure on township-level pulmonary tuberculosis notification rates during 2005-2017 in Ningxia, China. Environ Pollut. 2023 Jan 15;317:120718. doi: 10.1016/j.envpol.2022.120718. Epub 2022 Nov 23.

Merritt JD, Yen PN, Thu-Anh N, Ngo CQ, Giap VV, Nhung NV, Ha BT, Thuy MT, Anh NT, An NT, Marks GB, Negin J, Velen K, Fox GJ. Smoking behaviour, tobacco sales and tobacco advertising at 40 'Smoke Free Hospitals' in Vietnam. Tob Control. 2023 Sep 5:tc-2023-058003. doi: 10.1136/tc-2023-058003. Epub ahead of print.

Fregonese F, Apriani L, Barss L, Benedetti A, Cook V, Fisher D, Fox GJ, Johnston J, Long R, Nguyen TA, Nguyen VN, Ruslami R, Menzies D. High dose rifampin for 2 months vs standard dose rifampin for 4 months, to treat TB infection: Protocol of a 3-arm randomized trial (2R2). PLoS One. 2023 Feb 2;18(2):e0278087. doi: 10.1371/journal.pone.0278087.

Fotheringham P, Dorney E, McKinn S, Fox GJ, Bernays S. Protecting mental health in quarantine: Exploring lived experiences of healthcare in mandatory COVID-19 quarantine, New South Wales, Australia. SSM Popul Health. 2023 Mar;21:101329. doi: 10.1016/j.ssmph.2022.101329. Epub 2022 Dec 31.

Campbell JR, Chan ED, Anderson LF, Bonnet M, Brode SK, Cegielski JP, Guglielmetti L, Singla R, Fox GJ, Skrahina A, Rodrigues D, Kuksa L, Viiklepp P, Menzies D. Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes. Int J Tuberc Lung Dis. 2023 Apr 1;27(4):338-340. doi: 10.5588/ijtld.22.0678.

Velen K, Nguyen TA, Pham CD, Le HT, Nguyen HB, Dao BT, Nguyen TV, Nguyen NT, Nguyen NV, Fox GJ. The effect of medication event reminder monitoring on treatment adherence of TB patients. Int J Tuberc Lung Dis. 2023 Apr 1;27(4):322-328. doi: 10.5588/ijtld.22.0500.

Burman W, Fox GJ, Horsburgh CR. Treatment Strategy for Rifampin-Susceptible Tuberculosis. N Engl J Med. 2023 Jun 15;388(24):2296-2297. doi: 10.1056/NEJMc2304776.

Coleman M, Nguyen TA, Luu BK, Hill J, Ragonnet R, Trauer JM, Fox GJ, Marks GB, Marais BJ. Finding and treating both tuberculosis disease and latent infection during population-wide active case finding for tuberculosis elimination. Front Med (Lausanne). 2023 Oct 16;10:1275140. doi: 10.3389/fmed.2023.1275140.

Global Tuberculosis Network and TB/COVID-19 Global Study Group; Casco N, Jorge AL, Palmero DJ, Alffenaar JW, Fox GJ, Ezz W, Cho JG, Denholm J, Skrahina A, Solodovnikova V, Arbex MA, Alves T, Rabahi MF, Pereira GR, Sales R, Silva DR, Saffie MM, Salinas NE, Miranda RC, Cisterna C, Concha C, Fernandez I, Villalón C, Vera CG, Tapia PG, Cancino V, Carbonell M, Cruz A, Muñoz E, Muñoz C, Navarro I, Pizarro R, Cristina Sánchez GP, Vergara Riquelme MS, Vilca E, Soto A, Flores X, Garavagno A, Bahamondes MH, Merino LM, Pradenas AM, Revillot ME, Rodriguez P, Salinas AS, Taiba C, Valdés JF, Subiabre JN, Ortega C, Palma S, Castillo PP, Pinto M, Bidegain FR, Venegas M, Yucra E, Li Y, Cruz A, Guelvez B, Victoria Plaza R, Tello Hoyos KY, Cardoso-Landivar J, Van Den Boom M, Andréjak C, Blanc FX, Dourmane S, Froissart A, Izadifar A, Rivière F, Schlemmer F, Manika K, Diallo BD, Hassane-Harouna S, Artiles N, Mejia LA, Gupta N, Ish P, Mishra G, Patel JM, Singla R, Udwadia ZF, Alladio F, Angeli F, Calcagno A, Centis R, Codecasa LR, De Lauretis A, Esposito SMR, Formenti B, Gaviraghi A, Giacomet V, Goletti D, Gualano G, Matteelli A, Migliori GB, Motta I, Palmieri F, Pontali E, Prestileo T, Riccardi N, Saderi L, Saporiti M, Sotgiu G, Spanevello A, Stochino C, Tadolini M, Torre A, Villa S, Visca D, Kurhasani X, Furjani M, Rasheed N, Danila E, Diktanas S, Ridaura RL, Luna López FL, Torrico MM, Rendon A, Akkerman OW, Chizaram O, Al-Abri S, Alyaquobi F, Althohli K, Aguirre S, Teixeira RC, De Egea V, Irala S, Medina A, Sequera G, Sosa N, Vázquez F, Llanos-Tejada FK, Manga S, Villanueva-Villegas R, Araujo D, Sales Marques RD, Socaci A, Barkanova O, Bogorodskaya M, Borisov S, Mariandyshev A, Kaluzhenina A, Vukicevic TA, Stosic M, Beh D, Ng D, Ong CWM, Solovic I, Dheda K, Gina P, Caminero JA, De Souza Galvão ML, Dominguez-Castellano A, García-García JM, Pinargote IM, Fernandez SQ, Sánchez-Montalvá A, Huguet ET, Murguiondo MZ, Bart PA, Mazza-Stalder J, D'Ambrosio L, Kamolwat P, Bakko F, Barnacle J, Bird S, Brown A, Chandran S, Killington K, Man K, Papineni P, Ritchie F, Tiberi S, Utjesanovic N, Zenner D, Hearn JL, Heysell S, Young L. Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort. Eur Respir J. 2023 Nov 29;62(5):2300925. doi: 10.1183/13993003.00925-2023.

Dr Helen Jo

Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019. Med J Aust. 2023 Feb 20;218(3):138-139. doi: 10.5694/mja2.51797. Epub 2022 Dec 1.

Associate Professor Edmund Lau

Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019. Med J Aust. 2023 Feb 20;218(3):138-139. doi: 10.5694/mja2.51797. Epub 2022 Dec 1.

Chandrasekara S, Lau EM, Anderson J, Collins N, Cordina R, Corrigan C, Dwyer N, Feenstra J, Horrigan M, Keogh A, Kotlyar E, Lavender M, McWilliams T, Rhodes B, Steele P, Strange G, Thakkar V, Weintraub R, Whitford H, Whyte K, Williams T, Wrobel J, Keating DT; PHSANZ Registry. Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing. Heart Lung Circ. 2023 Feb;32(2):156-165. doi: 10.1016/j.hlc.2022.09.005. Epub 2022 Dec 8.

Hungerford S, Kearney K, Song N, Kotlyar E, Bart NK, Lau E, Jabbour A, Hayward CS, Muller DWM, Adji A. Characteristic changes to pulsatile and steady-state load according to pulmonary hypertension classification. Physiol Rep. 2023 Apr;11(7):e15662. doi: 10.14814/phy2.15662.

Kearney K, Lau EM. Pulmonary arterial compliance: a physiological variable still searching for clinical relevance? Heart. 2023 Jun 26;109(14):1052-1053. doi: 10.1136/heartjnl-2022-322222.

Hungerford SL, Kearney K, Song N, Bart N, Kotlyar E, Lau E, Jabbour A, Hayward CS, Muller DWM, Adji A. Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension. ESC Heart Fail. 2023 Jun;10(3):1811-1821. doi: 10.1002/ehf2.14180. Epub 2023 Mar 10.

Nguyen B, Menadue C, Yee B, McGuiness O, Wong K, Marshall N, Lau E, Piper A. O056 Is Obstruction Obstructing Survival? Long-term Mortality in Patients with Chronic Obstructive Pulmonary Disease (COPD) requiring Acute Non-invasive Ventilation (NIV) with and without Obstructive sleep apnoea (OSA). Sleep Adv. 2023 Oct 23;4(Suppl 1):A21–2.

Morland K, Gerges C, Elwing J, Visovatti SH, Weatherald J, Gillmeyer KR, Sahay S, Mathai SC, Boucly A, Williams PG, Harikrishnan S, Minty EP, Hobohm L, Jose A, Badagliacca R, Lau EMT, Jing ZC, Vanderpool RR, Fauvel C, Leonidas Alves J Jr, Strange G, Pulido T, Qian J, Li M, Mercurio V, Zelt JGE, Moles VM, Cirulis MM, Nikkho SM, Benza RL, Elliott CG. Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group. Pulm Circ. 2023 Dec 21;13(4):e12317. doi: 10.1002/pul2.12317.

Karimi Galougahi K, Zhang Y, Kienzle V, Liu CC, Quek LE, Patel S, Lau E, Cordina RL, Figtree GA, Celermajer DS. β3 adrenergic agonism: A novel pathway which improves right ventricular-pulmonary arterial hemodynamics in pulmonary arterial hypertension. Physiol Rep. 2023 Jan;11(1):e15549. doi: 10.14814/phy2.15549.

Associate Professor Amanda Piper

Qu Y, Milross M, McGuiness O, Menadue C, Piper AJ. Survey of home cleaning practices with noninvasive ventilation equipment. Cardiopulmonary Physical Therapy Journal 2023

Nguyen B, Menadue C, Yee B, McGuiness O, Wong K, Marshall N, Lau E, Piper A. O056 Is Obstruction Obstructing Survival? Long-term Mortality in Patients with Chronic Obstructive Pulmonary Disease (COPD) requiring Acute Non-invasive Ventilation (NIV) with and without Obstructive sleep apnoea (OSA). Sleep Adv. 2023 Oct 23;4(Suppl 1):A21–2.

Cheng MCF, Murphy PB, Lee K, McGowan B, Hart N, Piper A, Steier J. Screening and treatment of pre-bariatric surgical patients with obesity related sleep disordered breathing. J Thorac Dis. 2023 Jul 31;15(7):4066-4073. doi: 10.21037/jtd-23-112. Epub 2023 Jul 14.

Perry MA, Jones B, Devan H, Neill A, Piper A, Ingham T. Non-invasive ventilation for people with neuromuscular disorders in Australia and New Zealand: a qualitative study of clinician perspectives. Med J Aust. 2023 Sep 18;219(6):270-274. doi: 10.5694/mja2.52036. Epub 2023 Jul 14.

Lambrinos E, Elkins MR, Menadue C, McGuiness OA, Melehan KL, Piper AJ. Online Education Improves Confidence in Mechanical Insufflation-Exsufflation. Respir Care. 2023 Jul 11;69(1):91–8. doi: 10.4187/respcare.11031. Epub ahead of print.

Chang JL, Goldberg AN, Alt JA, Mohammed A, Ashbrook L, Auckley D, Ayappa I, Bakhtiar H, Barrera JE, Bartley BL, Billings ME, Boon MS, Bosschieter P, Braverman I, Brodie K, Cabrera-Muffly C, Caesar R, Cahali MB, Cai Y, Cao M, Capasso R, Caples SM, Chahine LM, Chang CP, Chang KW, Chaudhary N, Cheong CSJ, Chowdhuri S, Cistulli PA, Claman D, Collen J, Coughlin KC, Creamer J, Davis EM, Dupuy-McCauley KL, Durr ML, Dutt M, Ali ME, Elkassabany NM, Epstein LJ, Fiala JA, Freedman N, Gill K, Gillespie MB, Golisch L, Gooneratne N, Gottlieb DJ, Green KK, Gulati A, Gurubhagavatula I, Hayward N, Hoff PT, Hoffmann OMG, Holfinger SJ, Hsia J, Huntley C, Huoh KC, Huyett P, Inala S, Ishman SL, Jella TK, Jobanputra AM, Johnson AP, Junna MR, Kado JT, Kaffenberger TM, Kapur VK, Kezirian EJ, Khan M, Kirsch DB, Kominsky A, Kryger M, Krystal AD, Kushida CA, Kuzniar TJ, Lam DJ, Lettieri CJ, Lim DC, Lin HC, Liu SYC, MacKay SG, Magalang UJ, Malhotra A, Mansukhani MP, Maurer JT, May AM, Mitchell RB, Mokhlesi B, Mullins AE, Nada EM, Naik S, Nokes B, Olson MD, Pack AI, Pang EB, Pang KP, Patil SP, Van de Perck E, Piccirillo JF, Pien GW, Piper AJ, Plawecki A, Quigg M, Ravesloot MJL, Redline S, Rotenberg BW, Ryden A, Sarmiento KF, Sbeih F, Schell AE, Schmickl CN, Schotland HM, Schwab RJ, Seo J, Shah N, Shelgikar AV, Shochat I, Soose RJ, Steele TO, Stephens E, Stepnowsky C, Strohl KP, Sutherland K, Suurna MV, Thaler E, Thapa S, Vanderveken OM, de Vries N, Weaver EM, Weir ID, Wolfe LF, Woodson BT, Won CHJ, Xu J, Yalamanchi P, Yaremchuk K, Yeghiazarians Y, Yu JL, Zeidler M, Rosen IM. International Consensus Statement on Obstructive Sleep Apnea. Int Forum Allergy Rhinol. 2023 Jul;13(7):1061-1482. doi: 10.1002/alr.23079. Epub 2023 Mar 30.

Dr Helen Reddel

Levy ML, Bacharier LB, Bateman E, Boulet LP, Brightling C, Buhl R, Brusselle G, Cruz AA, Drazen JM, Duijts L, Fleming L, Inoue H, Ko FWS, Krishnan JA, Mortimer K, Pitrez PM, Sheikh A, Yorgancıoğlu A, Reddel HK. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. NPJ Prim Care Respir Med. 2023 Feb 8;33(1):7. doi: 10.1038/s41533-023-00330-1.

Zhou Y, Ampon MR, Abramson MJ, James AL, Maguire GP, Wood-Baker R, Johns DP, Marks GB, Reddel HK, Toelle BG. Respiratory Symptoms, Disease Burden, and Quality of Life in Australian Adults According to GOLD Spirometry Grades: Data from the BOLD Australia Study. Int J Chron Obstruct Pulmon Dis. 2023 Nov 30;18:2839-2847. doi: 10.2147/COPD.S425202.

Guo YL, Ampon MR, Poulos LM, Davis SR, Toelle BG, Marks GB, Reddel HK. Contribution of obesity to breathlessness in a large nationally representative sample of Australian adults. Respirology. 2023 Apr;28(4):350-356. doi: 10.1111/resp.14400. Epub 2022 Nov 6.

Zhou Y, Ampon MR, Abramson MJ, James AL, Maguire GP, Wood-Baker R, Johns DP, Marks GB, Reddel HK, Toelle BG. Risk factors and clinical characteristics of breathlessness in Australian adults: Data from the BOLD Australia study. Chron Respir Dis. 2023 Jan-Dec;20:14799731231221820. doi: 10.1177/14799731231221820.

Zhou Y, Ampon MR, Abramson MJ, James AL, Maguire GP, Wood-Baker R, Johns DP, Marks GB, Reddel HK, Toelle BG. Clinical characteristics of adults with self-reported diagnosed asthma and/or COPD: data from the BOLD Australia Study. ERJ Open Res. 2023 Aug 21;9(4):00098-2023. doi: 10.1183/23120541.00098-2023.

Krings JG, Gerald JK, Blake KV, Krishnan JA, Reddel HK, Bacharier LB, Dixon AE, Sumino K, Gerald LB, Brownson RC, Persell SD, Clemens CJ, Hiller KM, Castro M, Martinez FD. A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma. Am J Respir Crit Care Med. 2023 Feb 15;207(4):390-405. doi: 10.1164/rccm.202209-1729PP.

Cardet JC, Papi A, Reddel HK. "As-Needed" Inhaled Corticosteroids for Patients With Asthma. J Allergy Clin Immunol Pract. 2023 Mar;11(3):726-734. doi: 10.1016/j.jaip.2023.01.010. Epub 2023 Jan 24.

Tomaszewski EL, Atkinson MJ, Janson C, Karlsson N, Make B, Price D, Reddel HK, Vogelmeier CF, Müllerová H, Jones PW; NOVELTY Scientific Community; NOVELTY study investigators. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD. Respir Res. 2023 Apr 8;24(1):106. doi: 10.1186/s12931-023-02394-6.

Kocks JWH, Cao H, Holzhauer B, Kaplan A, FitzGerald JM, Kostikas K, Price D, Reddel HK, Tsiligianni I, Vogelmeier CF, Bostel S, Mastoridis P. Diagnostic Performance of a Machine Learning Algorithm (Asthma/Chronic Obstructive Pulmonary Disease [COPD] Differentiation Classification) Tool Versus Primary Care Physicians and Pulmonologists in Asthma, COPD, and Asthma/COPD Overlap. J Allergy Clin Immunol Pract. 2023 May;11(5):1463-1474.e3. doi: 10.1016/j.jaip.2023.01.017. Epub 2023 Jan 28.

Muiser S, Imkamp K, Seigers D, Halbersma NJ, Vonk JM, Luijk BHD, Braunstahl GJ, van den Berg JW, Kroesen BJ, Kocks JWH, Heijink IH, Reddel HK, Kerstjens HAM, van den Berge M. Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD. Thorax. 2023 May;78(5):451-458. doi: 10.1136/thorax-2022-219620. Epub 2023 Feb 1.

Chen W, Reddel HK, FitzGerald JM, Beasley R, Janson C, Sadatsafavi M. Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials. Respir Res. 2023 May 2;24(1):120. doi: 10.1186/s12931-023-02409-2.

Mohan A, Lugogo NL, Hanania NA, Reddel HK, Akuthota P, O'Byrne PM, Guilbert T, Papi A, Price D, Jenkins CR, Kraft M, Bacharier LB, Boulet LP, Yawn BP, Pleasants R, Lazarus SC, Beasley R, Gauvreau G, Israel E, Schneider-Futschik EK, Yorgancioglu A, Martinez F, Moore W, Sumino K. Questions in Mild Asthma: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2023 Jun 1;207(11):e77-e96. doi: 10.1164/rccm.202304-0642ST.

Ding B, Chen S, Srivastava D, Quinton A, Cook W, Papi A, Reddel HK; NOVELTY Scientific Community; NOVELTY study investigators. Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTY. J Asthma Allergy. 2023 Jun 11;16:611-624. doi: 10.2147/JAA.S401445.

Yorgancıoğlu A, Reddel HK; GINA Board of Directors and GINA Science Committee. Global initiative for asthma: 30 years of promoting evidence-based asthma care. Allergy. 2023 Jul;78(7):1737-1739. doi: 10.1111/all.15714.

Reddel HK, Brusselle G, Lamarca R, Gustafson P, Anderson GP, Jorup C. Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy. J Allergy Clin Immunol Pract. 2023 Jul;11(7):2104-2114.e3. doi: 10.1016/j.jaip.2023.03.046. Epub 2023 Apr 11.

Hughes R, Rapsomaniki E, Bansal AT, Vestbo J, Price D, Agustí A, Beasley R, Fageras M, Alacqua M, Papi A, Müllerová H, Reddel HK; NOVELTY Scientific Community; NOVELTY study investigators. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2803-2811. doi: 10.1016/j.jaip.2023.05.013. Epub 2023 May 23.

Levy ML, Bateman ED, Allan K, Bacharier LB, Bonini M, Boulet LP, Bourdin A, Brightling C, Brusselle G, Buhl R, Chakaya MJ, Cruz AA, Drazen J, Ducharme FM, Duijts L, Fleming L, Inoue H, Ko FWS, Krishnan JA, Masekela R, Mortimer K, Pitrez P, Salvi S, Sheikh A, Reddel HK, Yorgancıoğlu A. Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective. Lancet. 2023 Sep 16;402(10406):1012-1016. doi: 10.1016/S0140-6736(23)01358-2. Epub 2023 Jul 19.

Reddel HK. The GINA 2023 report. What’s new in asthma management. Respir Med Today; 2023.

Reddel HK et al. Global Initiative for Asthma. Short guide on management of difficult-to-treat and severe asthma in adults and adolescents. 2023. www.ginasthma.org/severeasthma/

Reddel HK et al. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2023. www.ginasthma.org

Reddel HK et al. Global Initiative for Asthma. Pocket Guide for asthma management and prevention. 2023. www.ginasthma.org

Dr Sheila Sivam

Stranks L, Ellender CM, Wong K, Naqvi H, Grunstein R, Yee BJ, Sivam S. Retrospective cohort study of hypersomnias of central origin from two Australian tertiary sleep disorders services. Intern Med J. 2023 Oct;53(10):1783-1789. doi: 10.1111/imj.15920. Epub 2022 Sep 17.

Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019. Med J Aust. 2023 Feb 20;218(3):138-139. doi: 10.5694/mja2.51797. Epub 2022 Dec 1.

Allan KM, Astore MA, Kardia E, Wong SL, Fawcett LK, Bell JL, Visser S, Chen PC, Griffith R, Jaffe A, Sivam S, Vittorio O, Kuyucak S, Waters SA. Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient. Front Mol Biosci. 2023 Jun 1;10:1148501. doi: 10.3389/fmolb.2023.1148501.

Doumit M, Chuang S, Middleton P, Selvadurai H, Sivam S, Ruseckaite R, Ahern S, Mallitt KA, Pacey V, Gray K, Jaffe A. Clinical outcomes of adults and children with cystic fibrosis during the COVID-19 pandemic. J Cyst Fibros. 2023 May;22(3):581-586. doi: 10.1016/j.jcf.2022.09.006. Epub 2022 Sep 16.

Doumit M, Strachan R, Lazarus R, Middleton P, Dentice R, Marouvo J, Jeffrey L, Selvadurai H, Sivam S, Pacey V, Jaffe A, Gray K. Screening for Cystic Fibrosis Related Complications in the Context of a Pandemic and Altered Models of Care. Health Serv Insights. 2023 Oct 16;16:11786329231205145. doi: 10.1177/11786329231205145.

Professor Paul Torzillo

Chang AB, Bell SC, Byrnes CA, Dawkins P, Holland AE, Kennedy E, King PT, Laird P, Mooney S, Morgan L, Parsons M, Poot B, Toombs M, Torzillo PJ, Grimwood K. Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand. Respirology. 2023 Apr;28(4):339-349. doi: 10.1111/resp.14479. Epub 2023 Mar 2.

Stoler S, van Hal SJ, Chadban S, Le T, Torzillo P, Scarlato RM, Wyburn K, Perkins GB, Marinelli T. Protracted COVID-19 pneumonitis early post-ABO incompatible kidney transplantation: Management considerations and the role of whole genome sequencing. Nephrology (Carlton). 2023 Nov;28(11):639-643. doi: 10.1111/nep.14235. Epub 2023 Aug 27.

Grimwood K, Kennedy E, Toombs M, Torzillo PJ, Chang AB. Chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand: TSANZ position statement summary. Med J Aust. 2023 Dec 11;219(11):516-519. doi: 10.5694/mja2.52160. Epub 2023 Nov 10.

Leach AJ, Wilson N, Arrowsmith B, Beissbarth J, Mulholland EK, Santosham M, Torzillo PJ, McIntyre P, Smith-Vaughan H, Skull SA, Oguoma VM, Chatfield M, Lehmann D, Binks MJ, Licciardi PV, Andrews R, Snelling T, Krause V, Carapetis J, Chang AB, Morris PS. Otitis media at 6-monthly assessments of Australian First Nations children between ages 12-36 months: Findings from two randomised controlled trials of combined pneumococcal conjugate vaccines. Int J Pediatr Otorhinolaryngol. 2023 Dec;175:111776. doi: 10.1016/j.ijporl.2023.111776. Epub 2023 Nov 6.

Associate Professor Lauren Troy

Lan D, Fermoyle CC, Troy LK, Knibbs LD, Corte TJ. The impact of air pollution on interstitial lung disease: a systematic review and meta-analysis. Front Med (Lausanne). 2024 Jan 17;10:1321038. doi: 10.3389/fmed.2023.1321038.

Lucas SEM, Raspin K, Mackintosh J, Glaspole I, Reynolds PN, Chia C, Grainge C, Kendall P, Troy L, Schwartz DA, Wood-Baker R, Walsh SLF, Moodley Y, Robertson J, Macansh S, Walters EH, Chambers D, Corte TJ, Dickinson JL. Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients. Pulmonology. 2023 May-Jun;29(3):257-260. doi: 10.1016/j.pulmoe.2022.09.002. Epub 2022 Oct 7.

Tikellis G, Corte T, Glaspole IN, Goh N, Khor YH, Wrobel J, Symons K, Fuhrmeister L, Glenn L, Chirayath S, Troy L, Holland AE. Understanding the telehealth experience of care by people with ILD during the COVID-19 pandemic: what have we learnt? BMC Pulm Med. 2023 Apr 6;23(1):113. doi: 10.1186/s12890-023-02396-6.

Glenn LM, Troy LK, Corte TJ. Novel diagnostic techniques in interstitial lung disease. Front Med (Lausanne). 2023 Apr 28;10:1174443. doi: 10.3389/fmed.2023.1174443.

Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I, Dellaripa PF, Gooptu B, Vassallo R, Cox PG, Flaherty KR, Adamali HI, Gibbons MA, Troy L, Forrest IA, Lasky JA, Spencer LG, Golden J, Scholand MB, Chaudhuri N, Perrella MA, Lynch DA, Chambers DC, Kolb M, Spino C, Raghu G, Goldberg HJ, Rosas IO; TRAIL1 Network Investigators. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. Lancet Respir Med. 2023 Jan;11(1):87-96. doi: 10.1016/S2213-2600(22)00260-0. Epub 2022 Sep 5.

Troy LK, Williamson JP. Mediastinal cryobiopsy: safe and effective but in whom and when? Lancet Respir Med. 2023 Mar;11(3):217-219. doi: 10.1016/S2213-2600(22)00410-6. Epub 2022 Oct 22.

Dr Simone Visser

Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019. Med J Aust. 2023 Feb 20;218(3):138-139. doi: 10.5694/mja2.51797. Epub 2022 Dec 1.

Allan KM, Astore MA, Kardia E, Wong SL, Fawcett LK, Bell JL, Visser S, Chen PC, Griffith R, Jaffe A, Sivam S, Vittorio O, Kuyucak S, Waters SA. Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient. Front Mol Biosci. 2023 Jun 1;10:1148501. doi: 10.3389/fmolb.2023.1148501.

Associate Professor Keith Wong

Judge DJ, Miller CB, Bartlett DJ, Jomaa I, Wong KKW, Saini B, Semsarian CR, Espie CA, Kyle SD, Grunstein RR, Yee BJ, Marshall NS. Armodafinil to reduce the sleepiness related side-effects of sleep restriction therapy being used to treat insomnia disorder: An open label clinical trial pilot study compared with historical controls. J Sleep Res. 2023 Feb;32(1):e13699. doi: 10.1111/jsr.13699. Epub 2022 Aug 24.

Stranks L, Ellender CM, Wong K, Naqvi H, Grunstein R, Yee BJ, Sivam S. Retrospective cohort study of hypersomnias of central origin from two Australian tertiary sleep disorders services. Intern Med J. 2023 Oct;53(10):1783-1789. doi: 10.1111/imj.15920. Epub 2022 Sep 17.

Cheung JM, Menczel Schrire Z, Aji M, Rahimi M, Salomon H, Doggett I, Glozier N, Bartlett DJ, Wong K, Grunstein RR, Gordon CJ. Embedding digital sleep health into primary care practice: A triangulation of perspectives from general practitioners, nurses, and pharmacists. Digit Health. 2023 Jun 23;9:20552076231180970. doi: 10.1177/20552076231180970.

D'Rozario AL, Kao CH, Phillips CL, Mullins AE, Memarian N, Yee BJ, Duffy SL, Cho G, Wong KKH, Kremerskothen K, Chapman J, Haroutonian C, Bartlett DJ, Naismith SL, Grunstein RR. Region-specific changes in brain activity and memory after continuous positive airway pressure therapy in obstructive sleep apnea: a pilot high-density electroencephalography study. Sleep. 2023 Dec 11;46(12):zsad255. doi: 10.1093/sleep/zsad255.

Nguyen B, Menadue C, Yee B, McGuiness O, Wong K, Marshall N, Lau E, Piper A. O056 Is Obstruction Obstructing Survival? Long-term Mortality in Patients with Chronic Obstructive Pulmonary Disease (COPD) requiring Acute Non-invasive Ventilation (NIV) with and without Obstructive sleep apnoea (OSA). Sleep Adv. 2023 Oct 23;4(Suppl 1):A21–2.

Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019. Med J Aust. 2023 Feb 20;218(3):138-139. doi: 10.5694/mja2.51797. Epub 2022 Dec 1.

Professor Brendon Yee

Judge DJ, Miller CB, Bartlett DJ, Jomaa I, Wong KKW, Saini B, Semsarian CR, Espie CA, Kyle SD, Grunstein RR, Yee BJ, Marshall NS. Armodafinil to reduce the sleepiness related side-effects of sleep restriction therapy being used to treat insomnia disorder: An open label clinical trial pilot study compared with historical controls. J Sleep Res. 2023 Feb;32(1):e13699. doi: 10.1111/jsr.13699. Epub 2022 Aug 24.

Stranks L, Ellender CM, Wong K, Naqvi H, Grunstein R, Yee BJ, Sivam S. Retrospective cohort study of hypersomnias of central origin from two Australian tertiary sleep disorders services. Intern Med J. 2023 Oct;53(10):1783-1789. doi: 10.1111/imj.15920. Epub 2022 Sep 17.

Teh JZ, Grummitt L, Haroutonian C, Cross NE, Skinner B, Bartlett DJ, Yee B, Grunstein RR, Naismith SL, D'Rozario AL. Overnight declarative memory consolidation and non-rapid eye movement sleep electroencephalographic oscillations in older adults with obstructive sleep apnea. Sleep. 2023 Jun 13;46(6):zsad087. doi: 10.1093/sleep/zsad087.

Lavender I, McCartney D, Marshall N, Suraev A, Irwin C, D'Rozario AL, Gordon CJ, Saini B, Grunstein RR, Yee B, McGregor I, Hoyos CM. Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial. BMJ Open. 2023 Aug 23;13(8):e071148. doi: 10.1136/bmjopen-2022-071148.

Tuft C, Matar E, Menczel Schrire Z, Grunstein RR, Yee BJ, Hoyos CM. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults. Clin Interv Aging. 2023 Jan 12;18:49-59. doi: 10.2147/CIA.S361519.

Aishah A, Loffler KA, Toson B, Mukherjee S, Adams RJ, Altree TJ, Ainge-Allen HW, Yee BJ, Grunstein RR, Carberry JC, Eckert DJ. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial. Ann Am Thorac Soc. 2023 Apr;20(4):584-595. doi: 10.1513/AnnalsATS.202206-492OC.

D'Rozario AL, Kao CH, Phillips CL, Mullins AE, Memarian N, Yee BJ, Duffy SL, Cho G, Wong KKH, Kremerskothen K, Chapman J, Haroutonian C, Bartlett DJ, Naismith SL, Grunstein RR. Region-specific changes in brain activity and memory after continuous positive airway pressure therapy in obstructive sleep apnea: a pilot high-density electroencephalography study. Sleep. 2023 Dec 11;46(12):zsad255. doi: 10.1093/sleep/zsad255.

Nguyen B, Menadue C, Yee B, McGuiness O, Wong K, Marshall N, Lau E, Piper A. O056 Is Obstruction Obstructing Survival? Long-term Mortality in Patients with Chronic Obstructive Pulmonary Disease (COPD) requiring Acute Non-invasive Ventilation (NIV) with and without Obstructive sleep apnoea (OSA). Sleep Adv. 2023 Oct 23;4(Suppl 1):A21–2.

2022

Professor Tamera Corte

Zheng Q, Cox IA, de Graaff B, Campbell JA, Corte TJ, Glaspole I, Navaratnam V, Hopkins P, Zappala C, Ahmad H, Zhao T, Macansh S, Walters EH, Palmer AJ. The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument. Qual Life Res. 2022 Dec 26. doi: 10.1007/s11136-022-03331-8. Epub ahead of print. PMID: 36572788.

Barnes H, Chambers D, Grainge C, Corte TJ, Bastiampillai S, Frenkel S, Westall G, Collard H, Glaspole I. Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire. Respirology. 2022 Nov 6. doi: 10.1111/resp.14404. Epub ahead of print. PMID: 36336654.

Cox IA, de Graaff B, Ahmed H, Campbell J, Otahal P, Corte TJ, Moodley Y, Goh N, Hopkins P, Macansh S, Walters EH, Palmer AJ. The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study. Eur J Health Econ. 2022 Oct 27. doi: 10.1007/s10198-022-01538-7. Epub ahead of print. PMID: 36289130.

Lucas SEM, Raspin K, Mackintosh J, Glaspole I, Reynolds PN, Chia C, Grainge C, Kendall P, Troy L, Schwartz DA, Wood-Baker R, Walsh SLF, Moodley Y, Robertson J, Macansh S, Walters EH, Chambers D, Corte TJ, Dickinson JL. Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients. Pulmonology. 2022 Oct 7:S2531-0437(22)00213-6. doi: 10.1016/j.pulmoe.2022.09.002. Epub ahead of print. PMID: 36216738.

Glenn LM, Troy LK, Corte TJ. Diagnosing interstitial lung disease by multidisciplinary discussion: A review. Front Med (Lausanne). 2022 Sep 21;9:1017501. doi: 10.3389/fmed.2022.1017501. PMID: 36213664; PMCID: PMC9532594.

Conway Morris A, Kohler K, De Corte T, Ercole A, De Grooth HJ, Elbers PWG, Povoa P, Morais R, Koulenti D, Jog S, Nielsen N, Jubb A, Cecconi M, De Waele J; ESICM UNITE COVID investigators. Correction: Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set. Crit Care. 2022 Aug 17;26(1):249. doi: 10.1186/s13054-022-04124-8. Erratum for: Crit Care. 2022 Aug 3;26(1):236. PMID: 35978317; PMCID: PMC9383662.

Cottin V, Selman M, Inoue Y, Wong AW, Corte TJ, Flaherty KR, Han MK, Jacob J, Johannson KA, Kitaichi M, Lee JS, Agusti A, Antoniou KM, Bianchi P, Caro F, Florenzano M, Galvin L, Iwasawa T, Martinez FJ, Morgan RL, Myers JL, Nicholson AG, Occhipinti M, Poletti V, Salisbury ML, Sin DD, Sverzellati N, Tonia T, Valenzuela C, Ryerson CJ, Wells AU. Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement. Am J Respir Crit Care Med. 2022 Aug 15;206(4):e7-e41. doi: 10.1164/rccm.202206-1041ST. PMID: 35969190.

Cox IA, Campbell J, de Graaff B, Otahal P, Corte TJ, Moodley Y, Hopkins P, Macansh S, Walters EH, Palmer AJ. Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D. Qual Life Res. 2022 Aug 4. doi:10.1007/s11136-022-03205-z. Epub ahead of print. PMID: 35927542.

Conway Morris A, Kohler K, De Corte T, Ercole A, De Grooth HJ, Elbers PWG, Povoa P, Morais R, Koulenti D, Jog S, Nielsen N, Jubb A, Cecconi M, De Waele J; ESICM UNITE COVID investigators. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set. Crit Care. 2022 Aug 3;26(1):236. doi: 10.1186/s13054-022-04108-8. Erratum in: Crit Care. 2022 Aug 17;26(1):249. PMID: 35922860; PMCID: PMC9347163.

Humphries SM, Mackintosh JA, Jo HE, Walsh SLF, Silva M, Calandriello L, Chapman S, Ellis S, Glaspole I, Goh N, Grainge C, Hopkins PMA, Keir GJ, Moodley Y, Reynolds PN, Walters EH, Baraghoshi D, Wells AU, Lynch DA, Corte TJ. Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis. Respirology. 2022 Dec;27(12):1045-1053. doi: 10.1111/resp.14333. Epub 2022 Jul 25. PMID: 35875881; PMCID: PMC9796832.

Molina-Molina M, Kreuter M, Cottin V, Corte TJ, Gilberg F, Kirchgaessler KU, Axmann J, Maher TM. Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post- hoc Analysis. Front Med (Lausanne). 2022 Jun 17;9:897102. doi:10.3389/fmed.2022.897102. PMID: 35783648; PMCID: PMC9247211.

Walsh SLF, Mackintosh JA, Calandriello L, Silva M, Sverzellati N, Larici AR, Humphries SM, Lynch DA, Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper WA, Mahar AM, Ellis S, Wells AU, Corte TJ. Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography. Am J Respir Crit Care Med. 2022 Oct 1;206(7):883-891. doi: 10.1164/rccm.202112-2684OC. PMID: 35696341.

Richeldi L, Azuma A, Cottin V, Hesslinger C, Stowasser S, Valenzuela C, Wijsenbeek MS, Zoz DF, Voss F, Maher TM; 1305-0013 Trial Investigators. Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis. N Engl J Med. 2022 Jun 9;386(23):2178-2187. doi: 10.1056/NEJMoa2201737. Epub 2022 May 15. PMID: 35569036.

Seth I, Bhagavata Srinivasan SP, Bulloch G, Yi DS, Frankel A, Hsu K, Passam F, Garsia R, Corte TJ. Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndrome. Respirol Case Rep. 2022 Apr 5;10(5):e0948. doi: 10.1002/rcr2.948. PMID: 35414937; PMCID: PMC8980908.

Cottin V, Tomassetti S, Valenzuela C, Walsh SLF, Antoniou KM, Bonella F, Brown KK, Collard HR, Corte TJ, Flaherty KR, Johannson KA, Kolb M, Kreuter M, Inoue Y, Jenkins RG, Lee JS, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nathan SD, Poletti V, Quadrelli S, Raghu G, Rajan SK, Ravaglia C, Remy-Jardin M, Renzoni E, Richeldi LK, Spagnolo P, Troy L, Wijsenbeek M, Wilson KC, Wuyts W, Wells AU, Ryerson CJ. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. Am J Respir Crit Care Med. 2022 Aug 1;206(3):247-259. doi: 10.1164/rccm.202111-2607PP. PMID: 35353660.

Zheng Q, Cox IA, Campbell JA, Xia Q, Otahal P, de Graaff B, Corte TJ, Teoh AKY, Walters EH, Palmer AJ. Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. ERJ Open Res. 2022 Mar 14;8(1):00591-2021. doi: 10.1183/23120541.00591-2021. PMID: 35295232; PMCID: PMC8918939.

Christian K, Hey-Cunningham A, Corte T, Goh N, Jaffar J, Reynolds P, Teoh A, Troy L. Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine. BMC Med Educ. 2022 Mar 1;22(1):136. doi: 10.1186/s12909-022-03169-1. PMID: 35232441; PMCID: PMC8886858.

Zanframundo G, Faghihi-Kashani S, Scirè CA, Bonella F, Corte TJ, Doyle TJ, Fiorentino D, Gonzalez-Gay MA, Hudson M, Kuwana M, Lundberg IE, Mammen A, McHugh N, Miller FW, Monteccucco C, Oddis CV, Rojas-Serrano J, Schmidt J, Selva-O'Callaghan A, Werth VP, Sakellariou G, Aggarwal R, Cavagna L. Defining anti-synthetase syndrome: a systematic literature review. Clin Exp Rheumatol. 2022 Feb;40(2):309-319. doi: 10.55563/clinexprheumatol/8xj0b9. Epub 2022 Feb 25. PMID: 35225224.

Kreuter M, Maher TM, Corte TJ, Molina-Molina M, Axmann J, Gilberg F, Kirchgaessler KU, Cottin V. Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use. Adv Ther. 2022 Feb;39(2):1081-1095. doi: 10.1007/s12325-021-02009-w. Epub 2021 Dec 22. PMID: 34936057; PMCID: PMC8866297.

Cox IA, Otahal P, de Graaff B, Corte TJ, Moodley Y, Zappala C, Glaspole I, Hopkins P, Macansh S, Walters EH, Palmer AJ. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia. Respirology. 2022 Mar;27(3):209-216. doi: 10.1111/resp.14194. Epub 2021 Dec 21. PMID: 34935240.

Tikellis G, Corte TJ, Teoh AKY, Glaspole IN, Macansh S, Holland AE. Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia. Respirology. 2022 Jan;27(1):76-84. doi: 10.1111/resp.14185. Epub 2021 Nov 15. PMID: 34783108.

Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, Maher TM, Navaratnam V, Hubbard R, Hopkins PMA, Reynolds PN, Chapman S, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh NS, De Jong E, Cha L, Tan DBA, Leigh L, Oldmeadow C, Walters EH, Jenkins RG, Moodley Y. Biomarker signatures for progressive idiopathic pulmonary fibrosis. Eur Respir J. 2022 Mar 31;59(3):2101181. doi: 10.1183/13993003.01181-2021. PMID: 34675050.

Hunninghake GM, Goldin JG, Kadoch MA, Kropski JA, Rosas IO, Wells AU, Yadav R, Lazarus HM, Abtin FG, Corte TJ, de Andrade JA, Johannson KA, Kolb MR, Lynch DA, Oldham JM, Spagnolo P, Strek ME, Tomassetti S, Washko GR, White ES; ILA Study Group. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative. Chest. 2022 Feb;161(2):470-482. doi: 10.1016/j.chest.2021.06.035. Epub 2021 Jun 29. PMID: 34197782.

Teoh AKY, Holland AE, Morisset J, Flaherty KR, Wells AU, Walsh SLF, Glaspole I, Wuyts WA, Corte TJ; ILD MDM Delphi Collaborators. Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi Survey. Ann Am Thorac Soc. 2022 Jan;19(1):66-73. doi:10.1513/AnnalsATS.202011-1421OC. PMID: 34191689.

Professor Gregory Fox

Marks, G., Ho, J., Nguyen, P., Nguyen, T., Boi, K., Nhung, N., Nguyen, H., Nguyen, L., Garden, F., Fox, G. (2022). A Direct Measure of Tuberculosis Incidence - Effect of Community Screening. New England Journal of Medicine, 386(14), 1380-1382.

Romanowski, K., Oravec, A., Billingsley, M., Shearer, K., Gupte, A., Huaman, M., Fox, G., Golub, J., Johnston, J. (2022). A scoping review of interventions to mitigate common non-communicable diseases among people with TB. International Journal of Tuberculosis and Lung Disease, 26(11), 1016-1022.

Huang, W., Marks, G., Pham, N., Nguyen, T., Nguyen, T., Vu, V., Nguyen, V., Jan, S., Negin, J., Ngo, Q., Fox, G. (2022). A smoking quitline integrated with clinician counselling at outpatient health facilities in Vietnam: a single-arm prospective cohort study. BMC Public Health, 22(1), 739.

Redwood, L., Mitchell, E., Nguyen, T., Viney, K., Duong, L., Pham, H., Nguyen, B., Nguyen, V., Fox, G. (2022). Adaptation and validation of the Van Rie tuberculosis stigma scale in Vietnam. International Journal of Infectious Diseases, 114, 97-104.

Ngoc Yen, P., Obeid, M., Quy Chau, N., Van Giap, V., Viet Nhung, N., Yen, N., Thi Ha, B., Nguyen, T., Marks, G., Freeman, B., Negin, J., Fox, G. (2022). Behaviors and Attitudes Toward Smoking Among Health Care Workers at Health Facilities in 4 Provinces of Vietnam: A Representative Cross-Sectional Survey. Asia-Pacific Journal of Public Health, 34(1), 79-86.

Alffenaar, J., Stocker, S., Davies Forsman, L., Garcia-Prats, A., Heysell, S., Aarnoutse, R., Akkerman, O., Aleksa, A., van Altena, R., de Oata, W., Cho, J., Fox, G., Kim, H., Marais, B., et al (2022). Clinical standards for the dosing and management of TB drugs. International Journal of Tuberculosis and Lung Disease, 26(6), 483-499.

Pahlman, K., Fehross, A., Fox, G., Silva, D. (2022). Ethical health security in the age of antimicrobial resistance. BMJ Global Health, 7(1), e007407-1-e007407-11.

Velen, K., Nguyen, V., Nguyen, B., Dang, T., Nguyen, H., Vu, D., Do, T., Pham Duc, C., Nguyen, H., Pham, H., Marais, B., Britton, W., Beardsley, J., Negin, J., Fox, G., et al (2022). Harnessing new mHealth technologies to Strengthen the Management of Multidrug-Resistant Tuberculosis in Vietnam (V-SMART trial): A protocol for a randomised controlled trial. BMJ Open, 12(6).

Zawahir, M., Le, H., Nguyen, T., Beardsley, J., Dang, A., Bernays, S., Viney, K., Cao, T., Drabarek, D., Tran, H., Marais, B., Negin, J., Marks, G., Fox, G., et al (2022). Inappropriate supply of antibiotics for common viral infections by community pharmacies in Vietnam: A standardised patient survey. The Lancet Regional Health. Western Pacific, 23, 100447.

Martinez, L., Cords, O., Liu, Q., Acuna-Villaorduna, C., Bonnet, M., Fox, G., Carvalho, A., Chan, P., Croda, J., Hill, P., et al (2022). Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. The Lancet Global Health, 10(9), e1307-e1316.

Coleman, M., Hill, J., Timeon, E., Tonganibeia, A., Eromanga, B., Islam, T., Trauer, J., Chambers, S., Christensen, A., Fox, G., Britton, W., Marais, B., et al (2022). Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol. BMJ Open, 12(4), e055295-1-e055295-10.

Wrohan, I., Nguyen, T., Nguyen, V., Nguyen, B., Hoang, T., Nguyen, P., Velen, K., Marks, G., Fox, G. (2022). Predictors of treatment outcomes among patients with multidrug-resistant tuberculosis in Vietnam: a retrospective cohort study. BMC Infectious Diseases, 22(1), 68.

Callum, J., Nguyen, P., Martinez, E., Nguyen, V., Garden, F., Nhung, N., Nguyen, T., Nguyen, H., Nguyen, S., Luu, K., Fox, G., et al (2022). Prevalence and genetic basis of first-line drug resistance of Mycobacterium tuberculosis in Ca Mau, Vietnam. ERJ Open Research, 8(4).

Hasan, T., Nguyen, V., Nguyen, H., Nguyen, T., Le, H., Pham, C., Do, N., Nguyen, P., Beardsley, J., Marks, G., Fox, G. (2022). Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020. Emerging Infectious Diseases, 28(3), 684-692.

Coorey, N., Kensitt, L., Davies, J., Keller, E., Sheel, M., Chani, K., Barry, S., Boyd, R., Denholm, J., Watts, K., Fox, G., Marais, B., Viney, K., et al (2022). Risk factors for TB in Australia and their association with delayed treatment completion. International Journal of Tuberculosis and Lung Disease, 26(5), 399-405.

Trinh, D., McKinn, S., Nguyen, A., Fox, G., Anh Thu, N., Bernays, S. (2022). Uneven stigma loads: Community interpretations of public health policies, evidence and inequities in shaping Covid-19 stigma in Vietnam. SSM - Population Health, 20.

Dr Laura Glenn

Glenn LM, Troy LK, Corte TJ. Diagnosing interstitial lung disease by multidisciplinary discussion: a review. Front Med. 2022;9:1017501.

Dr Helen Jo

Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, Maher TM, Navaratnam V, Hubbard R, Hopkins PMA, Reynolds PN, Chapman S, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh NS, De Jong E, Cha L, Tan DBA, Leigh L, Oldmeadow C, Walters EH, Jenkins RG, Moodley Y. Biomarker signatures for progressive idiopathic pulmonary fibrosis. Eur Respir J. 2022 Mar 31;59(3):2101181. doi: 10.1183/13993003.01181-2021. Print 2022 Mar.

Bell JM, Sivam S, Dentice RL, Dwyer TJ, Jo HE, Lau EM, Munoz PA, Nolan SA, Taylor NA, Visser SK, Yozghatlian VA, Wong KK. Quality of home spirometry performance amongst adults with cystic fibrosis. J Cyst Fibros. 2022 Jan;21(1):84-87. doi: 10.1016/j.jcf.2021.10.012. Epub 2021 Nov 10.

Walsh SLF, Mackintosh JA, Calandriello L, Silva M, Sverzellati N, Larici AR, Humphries SM, Lynch DA, Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper WA, Mahar AM, Ellis S, Wells AU, Corte TJ. Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography. Am J Respir Crit Care Med. 2022 Oct 1;206(7):883-891. doi: 10.1164/rccm.202112-2684OC.

Humphries SM, Mackintosh JA, Jo HE, Walsh SLF, Silva M, Calandriello L, Chapman S, Ellis S, Glaspole I, Goh N, Grainge C, Hopkins PMA, Keir GJ, Moodley Y, Reynolds PN, Walters EH, Baraghoshi D, Wells AU, Lynch DA, Corte TJ. Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis. Respirology. 2022 Dec;27(12):1045-1053. doi: 10.1111/resp.14333. Epub 2022 Jul 25.

Associate Professor Edmund Lau

Kearney K, Lau EM. Inherited thrombophilia in Chinese CTEPH patients: a rather common finding an uncommon condition. JACC Asia 2022;2:256-257.

Bell JM, Sivam S, Dentice RL, Dwyer TJ, Jo HE, Lau EM, Munoz PA, Nolan SA, Taylor NA, Visser SK, Yozghatlian VA, Wong KK. Quality of home spirometry perform ace amongst adults with cystic fiberosis. J Cyst Fibros 2022;21:84-87

Othman F, Bailey B, Collins N, Lau EM, Tanous D, Rao K, Celermajer D, Cordina R. Platypnoea-orthodeoxia syndrome in patent foramen ovale without pulmonary hypertension or major lung disease. J Am Heart Assoc. 2022;11:e024609.

Associate Professor Amanda Piper

Chang JL, Goldberg AN, ... Piper AJ, et al. International consensus statement on obstructive sleep apnea. Int Forum Allergy Rhinol. 2022 Sep 6.

Sivam S, Wang D, Wong KKH, Piper AJ, Zheng YZ, Gauthier G, Hockings C, McGuinness O, Menadue C, Melehan K, Cooper S, Hilmisson H, Phillips CL, Thomas RJ, Yee BJ, Grunstein RR. Cardiopulmonary coupling and serum cardiac biomarkers in obesity hypoventilation syndrome and obstructive sleep apnea with morbid obesity. J Clin Sleep Med. 2022 Apr 1;18(4):1063-1071.

Dennis CJ, Menadue C, Schneeberger T, Leitl D, Schoenheit-Kenn U, Harmer AR, Barnes DJ, Koczulla AR, Kenn K, Alison JA. Perceptions of Noninvasive Ventilation During Exercise in Noninvasive Ventilation-Naïve Patients With COPD. Respir Care. 2022 May;67(5):543-552

Qu Y, Milross M, McGuiness O, Menadue C, Piper AJ. Survey of home cleaning practices with noninvasive ventilation equipment. Cardiopulmonary Physical Therapy Journal.

Dr Sheila Sivam

Chetwood J, Koh C, Sivam S and Volovets A. Surgical Considerations in Cystic Fibrosis: What every general surgeon needs to know. ANZ Journal of Surgery. Oct 2022; 92 (10): 2425-2432.

Gudka SG, Haynes E, Scotney J, Mukherjee S, Frenkel S, Sivam S, Swieca J, Chamula K, Cunnington D and Saini B. Narcolepsy: comorbidities, complexities and future directions. Sleep Medicine Reviews. Oct 2022; 65: 101669.

Gardiner A, Volovets A, Haber P, Jo HE, Visser SK, Yozghatlian VA, Taylor N, Nolan S, Dentice R, Malouf M, Marinelli T and Sivam S. ELX/TEZ/IVA use in Cystic Fibrosis Liver Disease: Is the perspective of improved lung function worth the risk? Journal of Cystic Fibrosis. Sep 2022; 21(5): 881-884.

Bell J, Sivam S, Dentice R, Dwyer T, Jo H, Lau E, Munoz P, Nolan S, Taylor N, Visser S, Yozghatlian, and Wong, K. Quality of home spirometry performance amongst adults with Cystic Fibrosis. Journal of Cystic Fibrosis. Jan 2022; 21(1): 84-87.

Professor Paul Torzillo

Chang AB, Bell SC, Byrnes CA, Dawkins P, Holland AE, Kennedy E, King PT, Laird P, Mooney S, Morgan L, Parsons M, Poot B, Toombs M, Torzillo PJ, Grimwood K. Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand. Respirology. 2023 Apr;28(4):339-349.

Leach AJ, Wilson N, Arrowsmith B, Beissbarth J, Mulholland EK, Santosham M, Torzillo PJ, McIntyre P, Smith-Vaughan H, Chatfield MD, Lehmann D, Binks M, Chang AB, Carapetis J, Krause V, Andrews R, Snelling T, Skull SA, Licciardi PV, Oguoma VM, Morris PS. Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials. Lancet Infect Dis. 2022 Sep;22(9):1374-1387.

McCallum GB, Fong SM, Grimwood K, Nathan AM, Byrnes CA, Ooi MH, Nachiappan N, Saari N, Morris PS, Yeo TW, Ware RS, Elogius BW, Oguoma VM, Yerkovich ST, de Bruyne J, Lawrence KA, Lee B, Upham JW, Torzillo PJ, Chang AB. Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial. Pediatr Infect Dis J. 2022 Jul 1;41(7):549-555.

Chang AB, Toombs M, Chatfield MD, Mitchell R, Fong SM, Binks MJ, Smith-Vaughan H, Pizzutto SJ, Lust K, Morris PS, Marchant JM, Yerkovich ST, O'Farrell H, Torzillo PJ, Maclennan C, Simon D, Unger HW, Ellepola H, Odendahl J, Marshall HS, Swamy GK, Grimwood K. Study Protocol for Preventing Early-Onset Pneumonia in Young Children Through Maternal Immunisation: A Multi-Centre Randomised Controlled Trial (PneuMatters). Front Pediatr. 2022 Jan 17;9:781168.

Associate Professor Lauren Troy

Raghu G, Remy-Jardin M, Richeldi L...Troy LK et al. Idiopathic Pulmonary Fibrosis (an update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS / ERS / JRS / ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022.

Troy LK and Williamson JP. Invited editorial: Mediastinal cryobiopsy: safe and effective but in whom and when? Lancet Respir Med. 2022.

Solomon JJ, Danoff S, Woodhead F... Troy L.. Rosas I. A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease. Lancet Respir Med. 2022.

Glenn LM, Troy LK and Corte TJ. Diagnosing Interstitial Lung Disease by Multidisciplinary Discussion: A Review. Frontiers in Medicine. 2022.

Lucas SEM, Raspin K, Mackintosh J ... Troy L et al. Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients. Pulmonology. 2022.

Korevaar DA, Colella S, Fally M, ... Troy LK, et al. European Respiratory Society guidelines on transbronchial lung cryobiopsy in the diagnosis of interstitial lung diseases. Eur Respir J. 2022.

Marinescu D-C, Raghu G, Remy-Jardin M ... Troy LK, et al. Integration and application of clinical practice guidelines for the diagnosis of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis. Chest. 2022.

Kheir F, Becerra JPU, Bissell B, ... Troy L, et al. Transbronchial lung cryobiopsy in patients with interstitial lung disease: A systematic review. Ann Am Thorac Soc. 2022

Cottin V, Tomassetti S, Valenzuela C... Troy L et al. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. Am J Respir Crit Care Med. 2022.

Christian K, Hey-Cunningham A, Corte T...Troy L. Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine. BMC Med Ed. 2022

Dr Simone Visser

Bell JM, Sivam S, Dentice RL, Dwyer TJ, Jo HE, Lau EM, Munoz PA, Nolan SA, Taylor NA, Visser SK, Yozghatlian VA, Wong KK. Quality of home spirometry performance amongst adults with cystic fibrosis. J Cyst Fibros. 2022 Jan;21(1):84-87. doi: 10.1016/j.jcf.2021.10.012. Epub 2021 Nov 10.

Gardiner A, Volovets A, Haber P, Jo HE, Visser SK, Yozghatlian VA, Taylor N, Nolan S, Dentice R, Malouf M, Marinelli T and Sivam S. ELX/TEZ/IVA use in Cystic Fibrosis Liver Disease: Is the perspective of improved lung function worth the risk? J Cyst Fibros. Sep 2022; 21(5): 881-884

Associate Professor Keith Wong

Altree, T. J., Bartlett, D. J., Marshall, N. S., Hoyos, C. M., Phillips, C. L., Birks, C., . . . Cayanan, E. A. (2022). Predictors of weight loss in obese patients with obstructive sleep apnea. Sleep and Breathing, 26(2), 753-762.

Basheti, M. M., Tran, M., Wong, K., Gordon, C., Grunstein, R., & Saini, B. (2022). Australian consultant pharmacists' potential roles in sleep health care: Exploring a new avenue for improving the management of insomnia. Behavioral Sleep Medicine, 20(5), 622-637.

Bell, J. M., Sivam, S., Dentice, R. L., Dwyer, T. J., Jo, H. E., Lau, E. M., . . . Wong, K. K. (2022). Quality of home spirometry performance amongst adults with cystic fibrosis. Journal of Cystic Fibrosis, 21(1), 84-87.

D'Rozario, A. L., Hoyos, C. M., Wong, K. K. H., Unger, G., Kim, J. W., Vakulin, A., . . . Grunstein, R. R. (2022). Improvements in cognitive function and quantitative sleep electroencephalogram in obstructive sleep apnea after six months of continuous positive airway pressure treatment. Sleep, 45(6)

McLean, A. E. B., Kao, S. C., Barnes, D. J., Wong, K. K. H., Scolyer, R. A., Cooper, W. A., & Kohonen-Corish, M. R. J. (2022). The emerging role of the lung microbiome and its importance in non-small cell lung cancer diagnosis and treatment. Lung Cancer, 165, 124-132.

Sivam, S., Wang, D., Wong, K. K. H., Piper, A. J., Zheng, Y. Z., Gauthier, G., . . . Grunstein, R. R. (2022). Cardiopulmonary coupling and serum cardiac biomarkers in obesity hypoventilation syndrome and obstructive sleep apnea with morbid obesity. Journal of Clinical Sleep Medicine, 18(4), 1063-1071.

Vakulin, A., Green, M. A., D'Rozario, A. L., Stevens, D., Openshaw, H., Bartlett, D., . . . Rae, C. D. (2022). Brain mitochondrial dysfunction and driving simulator performance in untreated obstructive sleep apnea. Journal of Sleep Research, 31(2): e13482.

Professor Brendon Yee

Aishah A, Loffler KA, Toson B, Mukherjee S, Adams RJ, Altree TJ, Ainge-Allen HW, Yee BJ, Grunstein RR, Carberry JC, Eckert DJ. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo- controlled Trial. Ann Am Thorac Soc. 2022 Dec 20. doi: 10.1513/AnnalsATS.202206-492OC.

Stranks L, Ellender CM, Wong K, Naqvi H, Grunstein R, Yee BJ, Sivam S. Retrospective cohort study of hypersomnias of central origin from two Australian tertiary sleep disorders services. Intern Med J. 2022 Aug 31. doi: 10.1111/imj.15920. Epub ahead of print. PMID: 36043439.

Hoyos CM, Cross NE, Terpening Z, D'Rozario AL, Yee BJ, LaMonica H, Marshall NS, Grunstein RR, Naismith SL. Continuous Positive Airway Pressure for Cognition in Sleep Apnea and Mild Cognitive Impairment: A Pilot Randomized Crossover Clinical Trial. Am J Respir Crit Care Med. 2022 Jun 15;205(12):1479-1482. doi: 10.1164/rccm.202111-2646LE. PMID: 35584294.

Altree TJ, Bartlett DJ, Marshall NS, Hoyos CM, Phillips CL, Birks C, Kanagaratnam A, Mullins A, Serinel Y, Wong KKH, Yee BJ, Grunstein RR, Cayanan EA. Predictors of weight loss in obese patients with obstructive sleep apnea. Sleep Breath. 2022 Jun;26(2):753-762. doi: 10.1007/s11325-021-02455-4. Epub 2021 Aug 6. PMID: 34357505.

Sivam S, Wang D, Wong KKH, Piper AJ, Zheng YZ, Gauthier G, Hockings C, McGuinness O, Menadue C, Melehan K, Cooper S, Hilmisson H, Phillips CL, Thomas RJ, Yee BJ, Grunstein RR. Cardiopulmonary coupling and serum cardiac biomarkers in obesity hypoventilation syndrome and obstructive sleep apnea with morbid obesity. J Clin Sleep Med. 2022 Apr 1;18(4):1063-1071. doi: 10.5664/jcsm.9804. PMID: 34879904; PMCID: PMC8974389.

Phillips CL, Cayanan EA, Yee BJ. Predicting Weight-Loss Effects on Obstructive Sleep Apnea and Cardiometabolic Health: In Search of the Craniofacial "Holy Grail". Am J Respir Crit Care Med. 2022 Mar 15;205(6):614-616. doi: 10.1164/rccm.202112-2750ED. PMID: 35085472.

Zheng Y, Yee BJ, Wong K, Grunstein R, Piper A. A pilot randomized trial comparing CPAP vs bilevel PAP spontaneous mode in the treatment of hypoventilation disorder in patients with obesity and obstructive airway disease. J Clin Sleep Med. 2022 Jan 1;18(1):99-107. doi: 10.5664/jcsm.9506. PMID: 34170241; PMCID: PMC8807907.

2021

Ainge-Allen H, Yee B, Ip M. Sleep 2020; Contemporary Concise Review on Sleep. Respirology 2021 26(7) 700-706

Aronson KI, Danoff SK, Russell AM, Ryerson CJ, Suzuki A, Wijsenbeek MS, Bajwah S, Bianchi P, Corte TJ, Lee JS, Lindell KO, Maher TM, Martinez FJ, Meek PM, Raghu G, Rouland G, Rudell R, Safford MM, Sheth JS, Swigris JJ. Patient- centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2021 Jul 15;204(2):e3-e23. doi: 10.1164/rccm.202105-1193ST. Erratum in: Am J Respir Crit Care Med. 2021 Sep 1;204(5):616. PMID: 34283696; PMCID: PMC8650796.

Barnes, H, Troy L, Lee CT, Sperling A, Strek M, Glaspole I. Hypersensitivity pneumonitis: current concepts in pathogenesis, diagnosis and treatment. Allergy. 2021.

Bell J*, Sivam S* (Co-first author), Dentice R, Dwyer T, Jo H, Lau E, Munoz P, Nolan S, Taylor N, Visser S, Yozghatlian, and Wong, K. Quality of home spirometry performance amongst adults with Cystic Fibrosis. Journal of Cystic Fibrosis. Accepted for publication October 2021.

Chapman JL. Hoyos CM, Killick R, Sutherland K, Cistulli PA, Zwar N, Yee BJ, Marks G, Grunstein RR, Wong KHK on behalf of the Sydney-OSA-GP Study Investigators. Development and validation of a model for diagnosis of obstructive sleep apnea in primary care. Respirology 2021

Christian K, Hey-Cunningham A, Corte T...Troy L. Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine. BMC Med Ed. 2022

Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, Maher TM, Navaratnam V, Hubbard R, Hopkins PMA, Reynolds PN, Chapman S, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh NS, De Jong E, Cha L, Tan DBA, Leigh L, Oldmeadow C, Walters EH, Jenkins RG, Moodley Y. Biomarker signatures for progressive idiopathic pulmonary fibrosis. Eur Respir J. 2021 Oct 21:2101181. doi: 10.1183/13993003.01181-2021. Epub ahead of print. PMID: 34675050.

Cooper WA, Mahar A, Myers JL, Grainge C, Corte TJ, Williamson JP, Lau EMT, Raghu G, Troy LKT. In reply. Arch Pathol Lab Med. 2021.

Cooper WA, Mahar A, Myers JL, Grainge C, Corte TJ, Williamson JP, Vallely MP, Lai S, Mulyadi E, Torzillo PJ, Phillips MJ, Lau EMT, Raghu G, Troy LK. Cryobiopsy for identification of usual interstitial pneumonia and other interstitial lung disease features: further lessons from COLDICE. Am J Respir Med Crit Care. 2021 (editorialised).

Corte TJ, Lancaster L, Swigris JJ, Maher TM, Goldin JG, Palmer SM, Suda T, Ogura T, Minnich A, Zhan X, Tirucherai GS, Elpers B, Xiao H, Watanabe H, Smith RA, Charles ED, Fischer A. Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA<sub>1</sub>) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD). BMJ Open Respir Res. 2021 Dec;8(1):e001026. doi: 10.1136/bmjresp-2021-001026. PMID: 34969771; PMCID: PMC8718498.

Cottin V, Tomassetti S, Valenzuela C... Troy L et al. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. Am J Respir Crit Care Med. 2022.

Cox IA, de Graaff B, Ahmed H, Campbell J, Otahal P, Corte TJ, Glaspole I, Moodley Y, Goh N, Macansh S, Walters EH, Palmer AJ. The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia. Qual Life Res. 2021 Sep;30(9):2615-2632. doi: 10.1007/s11136-021-02879-1. Epub 2021 May 17. PMID: 33999322.

Cox IA, de Graaff B, Corte TJ, Glaspole I, Chambers DC, Moodley Y, Teoh A, Walters EH, Palmer AJ. Recent trends in pirfenidone and nintedanib use for idiopathic pulmonary fibrosis in Australia. Aust Health Rev. 2021 Dec;45(6):718-727. doi: 10.1071/AH20337. PMID: 34706811.

Dinh MM, Hutchings O, Bein KJ, Shaw J, Raut A, Berendsen S, Jagers D, Fox GJ, Edwards J, Britton WJ. Emergency department patients from quarantine hotels in Sydney Australia during the COVID19 outbreak - an analysis of presentation types and outcomes. Med J Aust 2021 214(10):473-4).*

Dowman LM, May AK, Hill CJ, Bondarenko J, Spencer L, Morris NR, Alison JA, Walsh J, Goh NSL, Corte T, Glaspole I, Chambers DC, McDonald CF, Holland AE. High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial. BMC Pulm Med. 2021 Nov 10;21(1):361. doi: 10.1186/s12890-021-01704-2. PMID: 34758808; PMCID: PMC8582173.

Drennan P, Thoma Y, Barry L, Sivam S and van Hal SJ. Bayesian forecasting for intravenous tobramycin dosing in adults with Cystic Fibrosis using one versus two serum concentrations in a dosing interval. Therapeutic Drug Monitoring 2021; 43(4): 505-511.

Duong TMN, Le TV, Tran KLH, Nguyen PT, Nguyen BPT, Nguyen TA, Nguyen HLP, Nguyen BNT, Fisher MC, Rhodes J, Marks G, Fox GJ, Chen SC-A, Walsh MG, Barrs VR, Talbot J, Halliday CL, Sorrell TC, Day JN, Beardsley J. Azole-resistant Aspergillus fumigatus is highly prevalent in the environment of Vietnam, with marked variability by land use type. Environ Microbiol 07 Jul 2021. https://doi.org/10.1111/1462-2920.15660.

Fawcett L, Wakefield C, Sivam S, Middleton P, Wark P, Widger J, Jaffe A, Waters S. Avatar acceptability: Views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions. ERJ Open Research 2021; 7(1): 00448-2020.

Fox GJ, Johnston JC, Nguyen TA, Majumdar SS, Denholm JT, Alsdurf H, Nguyen CB, Marks GB, Velen K. Active case-finding in contacts of people with TB. Int J Tuberc Lung Dis 2021 25(2): 95-105.*

Fox GJ, Nguyen TA, Coleman M, Trajman A, Velen K, Marais BM. Implementing tuberculosis preventive treatment in high-prevalence settings. Int J Infect Dis 2021. https://doi.org/10.1016/j.ijid.2021.02.094

Glenn LM, Pugashetti JV, Oldham J, Corte TJ. Interstitial pneumonia with autoimmune features: from research classification to diagnosis. Curr Opin Pulm Med. 2021 Sep 1;27(5):374-387. doi: 10.1097/MCP.0000000000000802. PMID: 34183525.

Gray EL, Forrest P, Southwood TJ, Totaro RJ, Plunkett BT, Torzillo PJ. Long-term outcomes of adults with acute respiratory failure treated with veno-venous extracorporeal membrane oxygenation. Journal Anaesthesia and Intensive Care, 2021;49(6):477-485

Guler SA, Corte TJ. Interstitial Lung Disease in 2020: A History of Progress. Clin Chest Med. 2021 Jun;42(2):229-239. doi: 10.1016/j.ccm.2021.03.001. PMID: 34024399.

Hasan T, Beardsley J, Marais BJ, Nguyen TA, Wood N, Fox GJ. The implementation of mass-vaccination against SARS-CoV-2: a systematic review of existing strategies and guidelines. Vaccines (Basel). 2021;9(4).

Hasan T, Pham TN, Nguyen TA, Le HTT, Van DL, Dang T, Van TD, Pham YN, Nguyen VH, Tran GL, Nguyen VTC, Nguyen TT, Truong VQ, Dao TH, Thanh CL, Truong NT, Ho HT, Le PT, Nguyen TT, Luu VV, Nguyen VD, Toelle BG, Marks GB, Fox GJ. Sero-prevalence of SARS-CoV-2 antibodies in high-risk populations in Vietnam. Int J Envir Res Pub H 2021 2021, 18(12), 6353; https://doi.org/10.3390/ijerph18126353.

Huang WC, Pham NY, Nguyen TA, Vu VG, Ngo QC, Nguyen VN, Freeman B, Jan S, Negin J, Marks GB, Fox GJ. Smoking behaviour among adult patients presenting to health facilities in four provinces of Vietnam. BMC Public Health. 2021 May 1;21(1):845. doi: 10.1186/s12889-021-10880-z. PMID: 33933063; PMCID: PMC8088640.

Jee AS, Parker MJS, Bleasel JF, Troy LK, Lau EM, Jo HE, Teoh AKY, Adelstein S, Webster S, Corte TJ. Baseline characteristics and survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort. Respiration. 2021.

Jee AS, Parker MJS, Bleasel JF, Troy LK, Lau EM, Jo HE, Teoh AKY, Webster S, Adelstein S, Corte TJ. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay. Respir Med. 2021 Oct;187:106581. doi: 10.1016/j.rmed.2021.106581. Epub 2021 Aug 21. PMID: 34454312.

Jee AS, Parker MJS, McGill N, Bleasel JF, Webster S, Troy LK, Corte TJ. Nailfold capillaroscopy by smartphone-dermatoscope for connective tissue disease diagnosis in interstitial lung disease: a prospective observational study. ERJ Open Res. 2021 Nov 8;7(4):00416-2021. doi: 10.1183/23120541.00416-2021. PMID: 34760999; PMCID: PMC8573234.

Jee AS, Sheehy R, Hopkins P, Corte TJ, Grainge C, Troy LK, Symons K, Spencer LM, Reynolds PN, Chapman S, de Boer S, Reddy T, Holland AE, Chambers DC, Glaspole IN, Jo HE, Bleasel JF, Wrobel JP, Dowman L, Parker MJS, Wilsher ML, Goh NSL, Moodley Y, Keir GJ. Diagnosis and management of connective tissue disease- associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand. Respirology. 2021 Jan;26(1):23-51. doi: 10.1111/resp.13977. Epub 2020 Nov 24. PMID: 33233015; PMCID: PMC7894187.

Kanjrawi AA, Mathers L, Webster S, Corte TJ, Carey S. Nutritional status and quality of life in interstitial lung disease: a prospective cohort study. BMC Pulm Med. 2021 Feb 5;21(1):51. doi: 10.1186/s12890-021-01418-5. PMID: 33546667; PMCID: PMC7863253.

Kheir F, Becerra JPU, Bissell B, Ghazipura M, Herman D, Hon SM, Hossain T, Khor YH, Knight SL, Kreuter M, Macrea M, Mammen MJ, Martinez FJ, Poletti V, Troy L, Raghu G, Wilson KC. Transbronchial lung cryobiopsy in patients with interstitial lung disease: A systematic review. Ann Am Thorac Soc. (In press). 2022

Kheir F, Becerra JPU, Bissell B, Ghazipura M, Herman D, Hon SM, Hossain T, Khor YH, Knight SL, Kreuter M, Macrea M, Mammen MJ, Martinez FJ, Poletti V, Troy L, Raghu G, Wilson KC. Use of a genomic classifier in patients with interstitial lung disease: a systematic review. Ann Am Thorac Soc. (In press). 2021.

Lam T, Dang DA, Tran HH, Do Van D, Le H, Negin J, Jan S, Marks G, Nguyen TA, Fox GJ, Beardsley J. What are the most effective community-based antimicrobial stewardship interventions in low and middle incomes countries? A narrative review. J Antimicrob Chemoth 2021;76(5):1117-29.

Lea, T., Grealy, L., Moskos, M., Brambilla, A., King, S., Habibis, D., Benedict, R., Phibbs, P., Sun, C., Torzillo, P. (2021). Sustainable Indigenous housing in regional and remote Australia. Australian Housing and Urban Research Institute Final Report, 368, 1-107.

Leach, A., Mulholland, E., Santosham, M., Torzillo, P., McIntyre, P., Smith-Vaughan, H., Wilson, N., Arrowsmith, B., Beissbarth, J., Chatfield, M., et al (2021). Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial. Vaccine: X, 7, 100086.

Leach, A., Mulholland, E., Santosham, M., Torzillo, P., McIntyre, P., Smith-Vaughan, H., Wilson, N., Arrowsmith, B., Beissbarth, J., Chatfield, M., et al (2021). Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial. BMC Pediatrics, 21(1), 117.

Liu G, Philp AM, Corte T, Travis MA, Schilter H, Hansbro NG, Burns CJ, Eapen MS, Sohal SS, Burgess JK, Hansbro PM. Therapeutic targets in lung tissue remodelling and fibrosis. Pharmacol Ther. 2021 Sep;225:107839. doi: 10.1016/j.pharmthera.2021.107839. Epub 2021 Mar 25. PMID: 33774068.

Mackintosh JA, Glenn L, Barnes H, Dunn E, Bancroft S, Reddy T, Teoh AKY, Troy L, Jo H, Geis M, Glaspole I, Grainge C, Corte TJ, Chambers DC, Hopkins P. Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19. Respirology. 2021 Jun;26(6):612-615. doi: 10.1111/resp.14062. Epub 2021 Apr 19. PMID: 33871150; PMCID: PMC8251432.

Mackintosh JA, Pietsch M, Lutzky V, Enever D, Bancroft S, Apte SH, Tan M, Yerkovich ST, Dickinson JL, Pickett HA, Selvadurai H, Grainge C, Goh NS, Hopkins P, Glaspole I, Reynolds PN, Wrobel J, Jaffe A, Corte TJ, Chambers DC. TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis. BMJ Open Respir Res. 2021 Dec;8(1):e001127. doi: 10.1136/bmjresp-2021-001127. PMID: 34857525; PMCID: PMC8640666.

McLean AEB, Gagnadoux F, Yee BJ. Blowing away fatty Liver: Mission Impossible? AJRCCM 2021 203(4):412-413

McLean, A., Webster, S., Fry, M., Lau, E., Corte, P., Torzillo, P., Troy, L., Jo, H., Geis, M., Rhodes, J., Spencer, L., Corte, T., et al (2021). Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic. Respirology, 26(1), 80-86.

Nambiar S, Clynick B, How BS, King A, Walters EH, Goh NS, Corte TJ, Trengove R, Tan D, Moodley Y. There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF). Respir Res. 2021 Apr 9;22(1):105. doi: 10.1186/s12931-021-01682-3. PMID: 33836757; PMCID: PMC8033725.

Nambiar S, Tan DBA, Clynick B, Bong SH, Rawlinson C, Gummer J, Corte TJ, Glaspole I, Moodley YP, Trengove R. Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Proteomics Clin Appl. 2021 May;15(2-3):e2000039. doi: 10.1002/prca.202000039. Epub 2021 Mar 18. PMID: 33580915.

Nathan SD, Cottin V, Behr J, Hoeper MM, Martinez FJ, Corte TJ, Keogh AM, Leuchte H, Mogulkoc N, Ulrich S, Wuyts WA, Yao Z, Ley-Zaporozhan J, Müller-Lisse UG, Scholle FD, Brüggenwerth G, Busse D, Nikkho S, Wells AU. Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study. J Heart Lung Transplant. 2021 Jun;40(6):494-503. doi: 10.1016/j.healun.2021.02.006. Epub 2021 Feb 19. PMID: 33744088.

Noth I, Cottin V, Chaudhuri N, Corte TJ, Johannson KA, Wijsenbeek M, Jouneau S, Michael A, Quaresma M, Rohr KB, Russell AM, Stowasser S, Maher TM; INMARK trial investigators. Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial. Eur Respir J. 2021 Jul 8;58(1):2001518 doi: 10.1183/13993003.01518-2020. PMID: 33419890; PMCID: PMC8264778.

Philip J, Collins A, Smallwood N, Chang YK, Mo L, Yang IA, Corte T, McDonald CF, Hui D. Referral criteria to palliative care for patients with respiratory disease: a systematic review. Eur Respir J. 2021 Oct 21;58(4):2004307. doi: 10.1183/13993003.04307-2020. PMID: 33737407.

Piper A. Long-term ventilatory support for children: there's no place like home. Respirology. 2021;26(10):902-903

Piper AJ. Initiating home non-invasive ventilation: How well are we doing? Respirology. 2021; 26(11):1014-1015

Polke M, Kondoh Y, Wijsenbeek M, Cottin V, Walsh SLF, Collard HR, Chaudhuri N, Avdeev S, Behr J, Calligaro G, Corte TJ, Flaherty K, Funke-Chambour M, Kolb M, Krisam J, Maher TM, Molina Molina M, Morais A, Moor CC, Morisset J, Pereira C, Quadrelli S, Selman M, Tzouvelekis A, Valenzuela C, Vancheri C, Vicens- Zygmunt V, Wälscher J, Wuyts W, Bendstrup E, Kreuter M. Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World. Front Med (Lausanne). 2021 Sep 27;8:699644. doi: 10.3389/fmed.2021.699644. PMID: 34646836; PMCID: PMC8502934.

Proudman SM, Corte TJ. Are serum biomarkers useful in the management of systemic sclerosis-associated interstitial lung disease? Respirology. 2021 May;26(5):406-408. doi: 10.1111/resp.14017. Epub 2021 Feb 20. PMID: 33611844.

Redwood L, Mitchell EHM, Viney KA, Snow K, Nguyen TA, Duong L, Nguyen VN, Fox GJ. Depression, stigma and quality-of-life in people with drug-susceptible TB and drug-resistant TB in Vietnam. Int J Tuberc Lung Dis 2021;25(6):461-7.

Redwood L, Mitchell EMH, Nguyen TA, Viney K, Nguyen VN, Fox GJ. Psychometric evaluation of a new drug-resistant tuberculosis stigma scale. J Clin Epi 2021 133:101-110. https://doi.org/10.1016/j.jclinepi.2021.01.007 *

Roswell L, Wu J, Yee BJ, Wong KKH, Sivam S, Somogyi A, Grunstein RR, Wang D. The Effect of Acute Morphine on Sleep: Is There a Genetic Effect?-an RCT Study J Sleep Res 2021

Rowsell L, Wu J, Yee BJ, Wong KKH, Sivam S, Somogyi AA, Grunstein RR and Wang D. The Effect of Acute Morphine on Sleep in Male Patients Suffering from Sleep Apnea: Is There a Genetic Effect? - an RCT Study. Journal of Sleep Research 2021; 30(4): e13249.

Ryerson CJ, Corte TJ, Myers JL, Walsh SLF, Guler SA. A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease. Eur Respir J. 2021 Dec 16;58(6):2100276. doi: 10.1183/13993003.00276-2021. PMID: 34140296; PMCID: PMC8674517.

Sivam S, Chamula K, Frenkel S, Mukherjee S, Swieca J and Saini B on behalf if the Australasian Sleep Association. The Challenge of Providing Access to First-Line Medicines for Patients with Narcolepsy in Australia.https://www.aph.gov.au/Parliamentary_Business/Committees/House/Health_A…. 2021.

Sivam S, Chamula K, Frenkel S, Swieca J and Saini B. Perspective: Narcolepsy Management in Australia: Time to Wake Up. Med J Aust. 2021; 215 (2): 62-63.

Sivam S, Singer R and Yee BJ. Editorial: Does CPAP improve CKD in OSA? It's still a maybe. Chest 2021;159 (5):1717-1718.

Sivam S, Singer R, Yee B. Effect of CPAP therapy on kidney function in patients with chronic kidney disease; a pilot randomised controlled trial. Chest 2021 159(5)1717-1718

Sivam S, Wang D, Wong K, Piper A, Zheng, Yi Zhong, Gauthier G, Hocking C, McGuinness O, Menadue C, Melehan K, Hilmisson H, Philips C, Thomas J, Yee B, Grunstein R. Cardiopulmonary Coupling and serum cardiac Biomarkers in Obesity Hypoventilation Syndrome and Obstructive Sleep Apnea with Morbid obesity. JCSM 2021

Sivam S, Yee BJ, Chadburn SJ, Piper AJ, Hanly P, Wang D, Wong K, Grunstein RR. Prevalence of Chronic Kidney Disease in Obesity Hypoventilation Syndrome and Obstructive Sleep Apnea and Obesity. Sleep Med 2021

Smith-Vaughan, H., Cheng, A., Tabrizi, S., Wurzel, D., Beissbarth, J., Leach, A., Morris, P., Binks, M., Torzillo, P., Chang, A., et al (2021). Absence of human papillomavirus in nasopharyngeal swabs from infants in a population at high risk of human papillomavirus infection. Global Journal of Emerging Market Economies, 5(2), 136-139.

Soon H, Sweeney S, Mudzengi D, Creswell J, Menzies NA, Fox GJ, MacPherson P, Dowdy DW. Determining the Value of Tuberculosis Active Case Finding: Current Evidence and Methodological Considerations for Economic Evaluation. Int J Tuber Lung Dis 2021 25(3) 171-181. http://dx.doi.org/10.5588/ijtld.20.0565.

Sutherland K, Yee BJ, Kairaitis K, Wheatley J, de Chazal P, Cistulli PA. A Phenotypic Approach for Personalised Management of Obstructive Sleep Apnea. Curr Otor Reports 2021 9:3 223-237

Teoh AKY, Corte TJ. Contemporary Concise Review 2020: Interstitial lung disease. Respirology. 2021 Jun;26(6):604-611. doi: 10.1111/resp.14063. Epub 2021 Apr 28. PMID: 33913200.

Thu-Anh N, Yen PN, Nhung DP, Thao NH, Toan DT, Giap VV, Marks GB, McKinn S, Joel N, Bernays S, Fox GJ. Factors affecting healthcare pathways for chronic lung disease management in Vietnam: a qualitative study on patients' perspectives. BMC Pub Health. 21(1):1145. 10.1186/s12889-021-11219-4

Tikellis G, Tong A, Lee JYT, Corte TJ, Hey-Cunningham AJ, Bartlett M, Crawford T, Glaspole I, Price J, Maloney J, Holland AE. Top 10 research priorities for people living with pulmonary fibrosis, their caregivers, healthcare professionals and researchers. Thorax. 2021 Jun;76(6):575-581. doi: 10.1136/thoraxjnl-2020-215731. Epub 2020 Dec 4. PMID: 33277429.

Tong, A., Sorrell, T., Black, A., Caillaud, C., Chrzanowski, W., Li, E., Martinez-Martin, D., McEwan, A., Wang, R., Motion, A., Casas Bedoya, A., Huang, J., Azizi, L., Eggleton, B., Andersen, T., Baillie, A., Barratt, A., Boehm, C., Britton, P., Chadban, S., Chow, C., Fleming, S., Fox, G., Gordon, L., Ho-Baillie, A., Howell, M., Hickie, I., Hunt, N., Iredell, J., Jin, C., Kairaitis, K., Kavehei, O., Kritharides, L., Leon-Saval, S., Lindley, R., Maguire, S., McCluskey, M., McKay, N., Mifsud, G., Palomba, S., Pettigrew, A., Postnova, S., Prinable, J., Rabeau, J., Rees, M., Richmond, K., Scholes Robertson, N., Seppelt, I., Shaw, T., Sintchenko, V., Snelling, T., Teixeira-Pinto, A., Tovey, E., Tuniz, A., Varamini, P., Wang, A., Wang, K., Wise, S., Zoellner, H. (2021). Research priorities for COVID-19 sensor technology. Nature Biotechnology, 39(2), 144-153

Wang D, Yee BJ, Chung F, Grunstein RR. Chronic opioid use and Central Sleep Apnea, Where are we now and where to go?-A State of the Art Review. Anaesthesia and Analgesia 2021 132(5):1244-1253

Zhao A, Gudmundsson E, Mogulkoc N, Jones MG, van Moorsel C, Corte TJ, Romei C, Savas R, Brereton CJ, van Es HW, Jo H, De Liperi A, Unat O, Pontoppidan K, van Beek F, Veltkamp M, Hopkins P, Moodley Y, Taliani A, Tavanti L, Gholipour B, Nair A, Janes S, Stewart I, Barber D, Alexander DC, Wells AU, Jacob J. Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema. ERJ Open Res. 2021 Aug 23;7(3):00316-2021. doi: 10.1183/23120541.00316-2021. PMID: 34435039; PMCID: PMC8381266.

Zheng Y, Piper A, Sivam S, Wong K, Grunstein R, Phillips C, Yee BJ. Cardiovascular Disease in Obesity Hypoventilation Syndrome-A review of Potential Mechanism and Effects of Therapy. Sleep Medicine Review 2021

Zheng Y, Yee BJ, Wong K, Grunstein R, Piper A. A pilot randomized trial comparing CPAP versus bilevel PAP spontaneous mode in the treatment of hypoventilation disorder in patients with obesity and obstructive airway disease. J Clin Sleep Med. 2021. doi: 10.5664/jcsm.9506. 5. Dennis CJ, Menadue C, Schneeberger T, Leitl D, Schoenheit-Kenn U, Hoyos CM, Harmer AR, Barnes DJ, Koczulla AR, Kenn K, Alison JA. Bilevel Noninvasive Ventilation During Exercise Reduces Dynamic Hyperinflation and Improves Cycle Endurance Time in Severe to Very Severe COPD. Chest 2021;160(6):2066-2079

Zheng Y, Yee BJ, Wong K, Grunstein R, Piper. A pilot randomised trial comparing CPAP versus Bi-level PAP in the treatment of hypoventilation disorder in obese patients with obstructive airways disease. JCSM 2021

Zheng YZ, Phillips C, Sivam S, Wong KKH, Grunstein RR, Piper AP and Yee BJ. Cardiovascular Disease in Obesity Hypoventilation Syndrome - A Review of Potential Mechanisms and Effects of Therapy. Sleep Medicine Reviews Aug 2021;60; 101530.

Zumla A, Chakaya J, Khan M, Fatima R, Wejse C, Al-Abri S, Fox GJ, Nachega J, Kapata N, Knipper M, Orcutt M, Gosce L, Abubakar I, Nagu TJ, Mugusi F, Gordon AK, Shanmugam S, Bachmann N, Lam C, Sintchenko V, Rudolf F, Amanullah F, Kock R, Haider N, Lipman M, King M, Maeurer M, Goletti D, Petrone L, Yaquoob A, Tiberi S, Ditiu L, Sahu S, Marais B, Petersen E. 'THE CLOCK IS TICKING' - and the world is running out of time to deliver the United Nations commitments to End TB due to the COVID-19 pandemic. Int J Infect Dis. 2021. 10.1016/j.ijid.2021.03.046 *

2020

Ainge-Allen, H., Yee, B. (2020). A moment on the lips, a lifetime on the mask: weight-loss programs and sleep apnea. The Journal of Clinical Sleep Medicine, 16(4), 471-472.

Alsdurf, H., Oxlade, O., Adjobimey, M., Ahmad Khan, F., Bastos, M., Bedingfield, N., Benedetti, A., Boafo, D., Buu, T., Chiang, L., Fox, G., et al (2020). Resource implications of the latent tuberculosis cascade of care: A time and motion study in five countries. BMC Health Services Research, 20(1), 341.

Anderson, J., Lau, E., Lavender, M., Benza, R., Celermajer, D., Collins, N., Corrigan, C., Dwyer, N., Feenstra, J., Horrigan, M., et al (2020). Retrospective Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort. Chest, 157(1), 162-172.

Anderson, J., Lavender, M., Lau, E., Celermajer, D., Collins, N., Dwyer, N., Feenstra, J., Horrigan, M., Keating, D., Keogh, A., et al (2020). Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges. Heart, Lung, and Circulation, 29(10), 1459-1468.

Clynick, B., Jo, H., Corte, T., Glaspole, I., Grainge, C., Hopkins, P., Reynolds, P., Chapman, S., Haydn Walters, E., Zappala, C., Cooper, W., Mahar, A., et al (2020). Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosis. European Respiratory Journal, 56(3), 1902058.

Cocozza, A., Linh, N., Nathavitharana, R., Ahmad, U., Jaramillo, E., Gargioni, G., Fox, G. (2020). An assessment of current tuberculosis patient care and support policies in high-burden countries. International Journal of Tuberculosis and Lung Disease, 24(1), 36-42.

Cox, I., Arriagada, N., De Graaff, B., Corte, T., Glaspole, I., Lartey, S., Walters, E., Palmer, A. (2020). Health-related quality of life of patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis. European Respiratory Review, 29(158), 1-22.

Fox, G., Nguyen, C., Nguyen, T., Tran, P., Marais, B., Graham, S., Nguyen, B., Velen, K., Mason, P., Britton, W., Marks, G., et al (2020). Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial. BMJ Open, 10(1), e033945.

Fox, G., Trauer, T., McBryde, E. (2020). Modelling the impact of COVID-19 on intensive care services in New South Wales. Medical Journal of Australia, 212(10), 468-469

Glenn, L., Corte, T. (2020). Diagnosing idiopathic pulmonary fibrosis: Has the time for surgical lung biopsy passed? Respirology, 25(11), 1112-1113.

Ho, J., Bokil, N., Nguyen, P., Nguyen, T., Liu, M., Hare, N., Fox, G., Saunders, B., Marks, G., Britton, W. (2020). A transcriptional blood signature distinguishes early tuberculosis disease from latent tuberculosis infection and uninfected individuals in a Vietnamese cohort. Journal of Infection, 81(1), 72-80.

Holland, A., Corte, T., Chambers, D., Palmer, A., Ekstrm, M., Glaspole, I., Goh, N., Hepworth, G., Khor, Y., Hoffman, M., Troy, L., et al (2020). Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): A randomised controlled trial. BMJ Open, 10(12), e040798.

Joshi, E., Nanayakkara, B., Barnes, D., Troy, L. (2020). Precision Medicine in Lung Cancer. European Medical Journal Oncology, 1, 1-12.

Khou, V., Anderson, J., Strange, G., Corrigan, C., Collins, N., Celermajer, D., Dwyer, N., Feenstra, J., Horrigan, M., Keating, D., Lau, E., et al (2020). Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry. Respirology, 25(8), 863-871.

Kreuter, M., Polke, M., Walsh, S., Krisam, J., Collard, H., Chaudhuri, N., Avdeev, S., Behr, E., Calligaro, G., Corte, T., et al (2020). Acute exacerbation of idiopathic pulmonary fibrosis: International survey and call for harmonisation. European Respiratory Journal, 55(4), 1901760.

Lau, E., Grainge, C., Williamson, J., Corte, T., Cooper, W., Phillips, M., Torzillo, P., Vallely, M., Raghu, G., Troy, L. (2020). Methodologies of COLDICE and Cryo-PID studies: details make the difference. Annals of Translational Medicine, 8(12), 781.

Lee, J., Tikellis, G., Corte, T., Goh, N., Keir, G., Spencer, L., Sandford, D., Khor, Y., Glaspole, I., Price, J., Hey-Cunningham, A., Teoh, A., et al (2020). The supportive care needs of people living with pulmonary fibrosis and their caregivers: A systematic review. European Respiratory Review, 29(156), 190125.

Lu, M., Yee, B., Fitzgerald, D. (2020). Transition to adult care in sleep medicine. Paediatric Respiratory Reviews, 33(0), 9-15.

Maher, T., Corte, T., Fischer, A., Kreuter, M., Lederer, D., Molina-Molina, M., Axmann, J., Kirchgaessler, K., Samara, K., Gilberg, F., et al (2020). Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet Respiratory Medicine, 8(2), 147-157.

Marais, B., Chakaya, J., Swaminathan, S., Fox, G., Ehtesham, N., Ntoumi, F., Zijenah, L., Maurer, M., Zumla, A. (2020). Tackling long-term morbidity and mortality after successful tuberculosis treatment. The Lancet Infectious Diseases, 20(6), 641-642.

Marks, G., Nguyen, N., Fox, G. (2020). Community-wide screening for tuberculosis. New England Journal of Medicine, 382(12), 1186.

Mason, P., Lyttleton, C., Marks, G., Fox, G. (2020). The technological imperative in tuberculosis care and prevention in Vietnam. Neurogastroenterology and Motility, 15(2), 307-320.

Mok, Y., Melehan, K., Phillips, C., Yee, B., Miller, C., Grunstein, R., Bartlett, D., Liu, P., Wong, K., Hoyos, C. (2020). Does CPAP treat depressive symptoms in individuals with OSA? An analysis of two 12-week randomized sham CPAP-controlled trials. Sleep Medicine, 73, 11-14.

Moore, I., Wrobel, J., Rhodes, J., Lin, Q., Webster, S., Jo, H., Troy, L., Grainge, C., Glaspole, I., Corte, T. (2020). Australasian interstitial lung disease registry (AILDR): Objectives, design and rationale of a bi-national prospective database. BMC Pulmonary Medicine, 20(1), 257.

Nanayakkara, B., Lau, E., Yee, B., Gauthier, G., Melehan, K., Celermajer, D., Cordina, R. (2020). Sleep disordered breathing in adults living with a Fontan circulation and CPAP titration protocol. International Journal of Cardiology, 317, 70-74.

Nguyen, T., Nguyen, T., Luu, B., Le, T., Nguyen, V., Nguyen, K., Duong, K., Nguyen, H., Nguyen, N., Fox, G., Nguyen, N., Marks, G. (2020). A comparison of digital chest radiography and XpertW MTB/RIF in active case finding for tuberculosis. International Journal of Tuberculosis and Lung Disease, 24(9), 934-940.

Parker, M., Corte, T. (2020). First risk, next reward? A new clinico-radiological risk model predicts mortality in rheumatoid arthritis-associated interstitial lung disease. Respirology, 25(12), 1225-1226.

Piper, A., Lau, E. (2020). Positive airway pressure in obesity hypoventilation: Getting to the heart of the matter. American Journal of Respiratory and Critical Care Medicine, 201(5), 509-511.

Raghu, A., Wilson, K., Bargagli, E., Bendstrup, E., Chami, H., Chua, A., Chung, J., Collins, B., Corte, T., Dalphin, J., et al (2020). Diagnosis of hypersensitivity pneumonitis in adults: An official ATS/JRS/ALAT clinical practice guideline. American Journal of Respiratory and Critical Care Medicine, 202(3), E36-E69.

Rankin, N., Fradgley, E., Barnes, D. (2020). Implementation of lung cancer multidisciplinary teams: A review of evidence-practice gaps. Translational Lung Cancer Research, 9(4), 1667-1679.

Ratwatte, S., Anderson, J., Strange, G., Corrigan, C., Collins, N., Celermajer, D., Dwyer, N., Feenstra, J., Keating, D., Kotlyar, E., Lau, E., et al (2020). Pulmonary arterial hypertension with below threshold pulmonary vascular resistance. European Respiratory Journal, 56(1), 1901654.

Sivam, S., Poon, J., Wong, K., Yee, B., Piper, A., D'Rozario, A., Wang, D., Grunstein, R. (2020). Slow-frequency electroencephalography activity during wake and sleep in obesity hypoventilation syndrome. Sleep, 43(2), 1-9.

Sivam, S., Yee, B., Chadban, S., Piper, A., Hanly, P., Wang, D., Wong, K., Grunstein, R. (2020). Prevalence of chronic kidney disease in obesity hypoventilation syndrome and obstructive sleep apnoea with severe obesity. Sleep Medicine, 74, 73-77.

Standen, J., Morgan, G., Sowerbutts, T., Blazek, K., Gugusheff, J., Puntsag, O., Wollan, M., Torzillo, P. (2020). Prioritising housing maintenance to improve health in indigenous communities in NSW over 20 years. International Journal of Environmental Research and Public Health, 17(16), 1-22.

Suraev, A., Grunstein, R., Marshall, N., D'Rozario, A., Gordon, C., Bartlett, D., Wong, K., Yee, B., Vandrey, R., Irwin, C., Arnold, J., McGregor, I., Hoyos, C. (2020). Cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial. BMJ Open, 10(5), e034421.

Teoh, A., Corte, T. (2020). Nonspecific Interstitial Pneumonia. Seminars in Respiratory and Critical Care Medicine, 41(2), 184-201.

Teoh, A., Glaspole, I., Macansh, S., Corte, T. (2020). Importance of Occupational Exposure Data: A National Idiopathic Pulmonary Fibrosis Registry Perspective. American Journal of Respiratory and Critical Care Medicine, 201(9), 1165-1167.

Teoh, A., Jo, H., Chambers, D., Symons, K., Walters, E., Goh, N., Glaspole, I., Cooper, W., Reynolds, P., Moodley, Y., Corte, T. (2020). Blood monocyte counts as a potential prognostic marker for IPF: Analysis from the Australian IPF registry. European Respiratory Journal, 55(4), 1901855.

Thanh, H., Van, T., Thu, H., Van, B., Thanh, B., Thu, H., Kieu, A., Viet, N., Marks, G., Fox, G., Nguyen, T. (2020). Outbreak investigation for COVID-19 in northern Vietnam. The Lancet Infectious Diseases, 20(5), 535-536.

Tikellis, G., Lee, J., Corte, T., Maloney, J., Bartlett, M., Crawford, T., Glaspole, I., Goh, N., Herrmann, K., Hey-Cunningham, A., Spencer, L., Teoh, A., Walsh, J., et al (2020). Peer Connect Service for people with pulmonary fibrosis in Australia: Participants' experiences and process evaluation. Respirology, 25(10), 1053-1059.

Troy, L., Grainge, C., Corte, T., Williamson, J., Vallely, M., Cooper, W., Mahar, A., Myers, J., Lai, S., Mulyadi, E., Torzillo, P., Jo, H., Harris, B., Lau, E., et al (2020). Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. The Lancet Respiratory Medicine, 8(2), 171-181

Wang, D., Phillips, C., Yee, B., Grunstein, R. (2020). Linking awake ventilatory chemosensitivity with opioid-induced respiratory depression during sleep-an important, but not a new, concept. Journal of Applied Physiology, 129(4), 932.

Wu, J., Wang, D., Rowsell, L., Wong, K., Yee, B., Nguyen, C., Han, F., Hilmisson, H., Thomas, R., Grunstein, R. (2020). The effect of acute exposure to morphine on breathing variability and cardiopulmonary coupling in men with obstructive sleep apnea: A randomized controlled trial. Journal of Sleep Research, 29(2), e12930.

Respiratory Medicine Research

Selected Grants

Our Publications

2024

Respiratory Medicine Research

Respiratory Medicine Research

Our Organisation

Make a Donation

Our Hospitals

Care in our Community

Right to Information

Your feedback

Plans

Publications

Quick Links